Part I. Total Synthesis and Structural Revision of (±)-Tricholomalides A and B. Part II. Synthetic Studies towards (+)-Cortistatin A by Wang, Zhang
 Part I. Total Synthesis and Structural Revision of 
(±)-Tricholomalides A and B 
Part II. Synthetic Studies towards (+)-Cortistatin A 
 





Submitted in partial fulfillment of the 
Requirements for the degree of 
Doctor of Philosophy 




















All Rights Reserved 
 
ABSTRACT 
Part I. Total Synthesis and Structural Revision of (±)-Tricholomalides A and B 
Part II. Synthetic Studies towards (+)-Cortistatin A 
Zhang Wang 
 
The first part describes the total synthesis and structural revision of 
(±)-tricholomalides A and B. The synthetic strategy started from a homo-Robinson 
annulation, followed by a ketene-olefin [2+2] cycloaddition to introduce the lactone 
ring. Then a Grignard-type reaction appended the isopropenyl moiety, and the 
synthesis of tricholomalides A and B was achieved. During the course of synthesis, 
the structures of tricholomalides A and B were revised. 
The second part describes the synthetic studies towards (+)-cortistatin A, especially 
the A ring functionalization. The C3 nitrogen was introduced by azide displacement, 
and C2 hydroxyl was built up by Luche reduction. The challenging C1 
functionalization was achieved with bromine-induced methoxymethyl deprotection, 
and some interesting chemistry was found in this system. The synthetic endeavor set a 
promising stage for the total synthesis of cortistatin A. 
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Part I: Total Synthesis and Structural Revision of 












1.1 Brief Introduction of Neurodegenerative Diseases and Natural Products1 
Neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and 
Huntington’s disease, have been more prevalent worldwide as aging of our population 
becomes an important social issue, especially in developed countries. In 2006, there were 
26.6 million people in the world who were suffering Alzheimer’s disease, and it was 
estimated that 1 in 85 persons would live with this disease by 2050. This prediction is 
likely to cost a large amount of money for healthcare and medical treatment, but also 
impair patients’ lives.2 
Neurodegenerative diseases are often associated with progressive loss of neurons.3 
Thus, maintaining neuron level in the nervous system will improve patients’ cognition 
and movement and also prevent further deterioration caused by unwanted death of 
neurons. Neuronal growth is modulated by a series of small proteins, called neurotrophins. 
Neurotrophins are categorized into (1) nerve growth factor (NGF), (2) Brain-derived 
neurotrophic factor (BDNF), (3) neurotrophin 3 (NT-3) and (4) neurotrophin 4/5 
(NT-4/5).4 Neurotrophins are also essential to neurons’ differentiation and development. 
Therefore, maintaining a reasonable level of neurotrophins in patients’ nervous system by 
using a method to boost neurotrophin secretion, or seeking neurotrophin substituents, 
would serve as a potential treatment for neurodegenerative diseases. The latter idea 
                                                            
1 Part I was adapted from our published results: (a) Min, S.-J.; Danishefsky, S. J. Tetrahedron Lett. 2008, 49, 3496 – 
3499. (b) Wang, Z.; Min, S.-J.; Danishefsky, S. J. J. Am. Chem. Soc. 2009, 131, 10848 – 10849. 
2 Brookmeyer, R.; Johnson, E.; Ziegler-Graham, K.; Arrighi, H. M. Johns Hopkins University, Dept. of Biostatistics 
Working Papers 2007, Paper 130. 
3 Abdipranoto, A.; Wu, S.; Stayte, S.; Vissel, B. CNS & Neurological Disorders – Drug Targets 2008, 7, 197 – 210. 
4 Holtzman, D. M.; Mobley, W. C. West. J. Med. 1994, 161, 246 – 254. 
3 
prompted scientists to seek small molecule natural products that might have neurotrophic 
activity. 
Our group has been involved in total synthesis of natural products with promising 
biological activity, such as antibiotic, anticancer, immunosuppressive, and neurotrophic 
natural products.5 Neurotrophic natural products are categorized into different groups 
based on their function and mechanism, 6  and the neurotrophic natural products 
synthesized in our group generally fall into two classes:5d (1) nonpeptidyl 
neurotrophically active agents and (2) natural products to help to maintain acetylcholine 
level in nervous system. Those neurotrophic natural products could serve as potential lead 
compounds for drug research and development. And through diverted total synthesis,5c, 5d 
therapeutics for neurodegenerative diseases might be found. 
 
1.2 Background of Tricholomalides and Others’ Synthetic Studies 
Tricholomalides A - C (1 - 3) belong to a family of diterpenes isolated from the 
mushroom Tricholoma sp. by the Ohta group in 2003.7 They were reported to exhibit 
neurotrophic activity and were shown to induce neurite outgrowth in rat 
pheochromocytoma cells (PC-12) in the micromolar range.  It has been suggested that 
these tricholomalides might even serve as neurotrophin substituents that might pass 
                                                            
5 (a) Danishefsky, S. J.; Shair, M. D. J. Org. Chem. 1996, 61, 16 – 64. (b) Harris, C. R.; Danishefsky, S. J. J. Org. 
Chem. 1999, 64, 8434 – 8456. (c) Wilson, R. M.; Danishefsky, S. J. J. Org. Chem. 2006, 71, 8329 – 8351. (d) Wilson, 
R. M.; Danishefsky, S. J. Acc. Chem. Res. 2006, 39, 539 – 549. 
6 Clement, J. A.; Yoder, B. J.; Kingston, D. G. I. Mini-Rev. Org. Chem. 2004, 1, 183–208. 
7 Tsukamoto, S.; Macabalang, A. D.; Nakatani, K.; Obara, Y.; Nakahata, N.; Ohta, T. J. Nat. Prod. 2003, 66, 1578 – 
1581. Unless notified otherwise, all numberings in this part are based on the numbering system of tricholomalide A. 
4 
blood-brain barrier to boost neurons’ survival and function. Structurally, tricholomalides 
share a 5-7 fused ring system. Particularly, tricholomalide A (1) is a tetracyclic structure 
and with different oxidation level on carbons, and in the central seven-membered ring, six 
of the carbon atoms are stereogenenic centers, two of which are contiguous quaternary 
carbon centers. In addition to their biological activity, the synthetic challenges of the 
tricholomalides attracted us to embark on their total synthesis. And in our synthetic 
studies, we corrected the structures for tricholomalides A (1) and B (2) (Scheme 1). 











































































In 1995, a family of natural products with close structural similarity to tricholomalides, 
called trichoaurantianolides, were isolated from the mushroom tricholoma aurantium 
(Scheme 2). 8  The only structural difference of tricholomalide C (3) and 
trichoaurantianolide B is the configuration of C8. All of the trichoaurantianolides have a 
                                                            
8 (a) Invernizzi, A. G.; Vidari, G.; Vita-Finzi, P. Tetrahedron Lett. 1995, 36, 1905 - 1908. (b) Benevelli, F.; Carugo, O.; 
Invernizzi, A. G.; Vidari, G. Tetrahedron Lett. 1995, 36, 3035 - 3038. 
5 
lactone moiety formed by bis-allylic alcohol on C2 and carboxylic acid on C5, similar to 
tricholomalide C (3). 
Scheme 2. Trichoaurantianolides A – D 
 
Considering their structural similarity, it is thought that the trichoaurantianolides and 
tricholomalides may have similar biosynthetic pathways. Thus, based on the proposal by 
Vidari group,8a geranyl geranyl pyrophosphate undergoes cationic polyene cyclization, 
furnishing dolabellane skeleton. A series of Meerwein rearrangements result in the 
correct stereochemistry for C10, C11, and C14. The macrocycle of dolabellane skeleton 
cyclized to form new structures of neodolabellane or dolastane frame, both of which form 
a new frame of 5-7-6 fused ring system (tentatively named as ‘neodolastane’ by Vidari 
group in 1995). Interestingly, five years later, representatives of the ‘neodolastane’ 
natural products were finally discovered in nature. We know that the ‘neodolastane’ is 
currently called ‘guanacastane’, as represented by the guanacastepene family natural 
products. 9  Oxidative cleavage between C4 and C5 furnishes trichoaurantiane 
(tricholomalide) skeleton. Different oxidation level on carbons are tuned and then the C5 
carboxylic acid cyclizes with hydroxyl on C8 or C2 to give tricholomalides and 
trichoaurantianolides, respectively (Scheme 3). 
                                                            
9 (a) Brady, S. F.; Singh, M. P.; Janso, J. E.; Clardy, J. J. Am. Soc. Chem. 2000, 122, 2116 – 2117. (b) Brady, S. F.; 
Bondi, S. M.; Clardy, J. J. Am. Soc. Chem. 2001, 123, 9900 – 9901. 
6 
Scheme 3. Biosynthetic Proposal for Tricholomalides and Trichoaurantianolides 
 
7 
Besides our synthetic studies, the Wright group (then at Dartmouth College) also 
published their research progress towards tricholomalide A synthesis (Scheme 4).10 
Their strategy takes advantages of the relationship of A ring ketone and D ring 
tetrahydrofuran. Thus, if D ring is considered as furan, the B ring might be formed 
between α positions of D ring furan and A ring ketone via oxidative coupling. Their work 
features an electrochemical annulation to form the central seven-membered B ring. In 
detail, silyl enol ether was oxidized through a single-electron-transfer (SET) process, and 
the radical formed intramolecularly cyclizes at the α-position of furan, and the hydrofuran 
radical is further oxidized and after losing proton, regenerates furan. 
Scheme 4. Synthetic Studies of Tricholomalide A by Wright Group 
 
 
1.3 Our Synthetic Plan 
  Regarding the relationship of guanacastepenes and tricholomalides, the guanacastepene 
synthesis might be useful for the tricholomalide project. In 2002, our group disclosed the 
first total synthesis of guanacastepene A,11 featuring two key annulative transformations, 
                                                            
10 (a) Sperry, J. B.; Wright, D. L. J. Am. Chem. Soc. 2005, 127, 8034 – 8035. (b) Sperry, J. B.; Wright, D. L.  
Tetrahedron, 2006, 62, 6551 – 6557. 
11 (a) Tan, D. S.; Dudley, G. B.; Danishefsky, S. J. Angew. Chem. Int. Ed. 2002, 41, 2185 – 2188. (b) Lin, S.; Dudley, 
G. B.; Tan, D. S.; Danishefsky, S. J. Angew. Chem. Int. Ed. 2002, 41, 2188 – 2191. (c) Mandal, M.; Yun, H.; Dudley, 
G. B.; Lin, S.; Tan, D. S.; Danishefsky, S. J. J. Org. Chem. 2005, 70, 10619 – 10637. 
8 
and the first annulation led to the formation of the central seven-membered ring. We 
believed we could use a similar global strategy of annulations to set up the A-B carbon 
ring system and then install the C ring and D ring. 
  As widely used in steroid synthesis, the Robinson annulation approach12 is quite 
efficient in building up six-membered rings, and the resulting cyclohexenone sets the 
stage for further functionalization. However, although equivalents of the Robinson 
annulation have been developed,12b, 12c the homology of this classic transformation has 
not attracted much attention. The homo-Robinson transformation starts from a regular 
Robinson annulation, followed by ring expansion that results in the cycloheptenone motif. 
We believed we could set up the 5-7 fused hydroazulene ring system first and then install 
the lactone moiety and tetrahydrofuran moiety of tricholomalide A. 
The tetrahydrofuran moiety was proposed to be synthesized through a tethered 
Nozaki-Hiyama-Kishi (NHK) reaction.13 After saponification, a lactonization would 
introduce the lactone moiety. The key step of this plan is to set up C5 stereochemistry 




12 (a) Rapson, W. S.; Robinson, R. J. Chem. Soc. 1935, 1285 – 1288. (b) Gawley, R. E. Synthesis 1976, 777 – 794. (c) 
Jung, M. E. Tetrahedron, 1976, 32, 3 – 31. 
13 (a) Okude, Y.; Hirano, S.; Hiyama, T.; Nozaki, H. J. Am. Chem. Soc. 1977, 99, 3179 – 3181. (b) Jin, H.; Uenishi, J.; 
Christ, W. J.; Kishi, Y. J. Am. Chem. Soc. 1986, 108, 5644 – 5646. (c) Takai, K.; Tagashira, M.; Kuroda, T.; Oshima, 
K.; Utimoto, K.; Nozaki, H. J. Am. Chem. Soc. 1986, 108, 6048 – 6050. (d) Takai, K. Org. React. (John Wiley & 
Sons, Inc.), 2004, 64, 253 – 335. (e) 2-Bromoallyl acetate has been used in NHK reaction, and C-C bond formation 
outcompetes elimination of acetate, see: Taylor, R. E.; Ciavarri, J. P. Org. Lett. 1999, 1, 467 – 469. 
9 
Scheme 5. Original Synthetic Plan 
 
 
1.4 Early Synthetic Studies 
The tricholomalide project was first initiated by our previous graduate student Dr. 
Heedong Yun, and was taken over by a postdoc associate Dr. Stefan Redlich. Later the 
relay continued, and another postdoc associate Dr. Sun-Joon Min made his contributions 
to this project. I started this project after Sun-Joon went back to Korea for a faculty 
position. Here I will summarize all the previous work before I started. 
1.4.1 The homo-Robinson approach 
In the synthesis of guanacastepene from our group, a key intramolecular 
Horner-Wadsworth-Emmons cyclization was found unsuccessful,11a, 11c and compound 7 
was isolated instead of the desired product 6. It could be conceived that 6 was actually 
formed through the Horner-Wadsworth-Emmons reaction but was not stable under the 
basic conditions, and retro-aldol and aldol reactions finally drove the equilibrium into the 
10 
most stable product 7. Thus, in the tricholomalide synthesis, the homo-Robinson strategy 
was used and finally delivered the desired intermediate (Scheme 6). 
Scheme 6. Attempted Horner-Wadsworth-Emmons Reaction 
 
Enone 4 was synthesized according to literature procedures.14, 15 The next aim was to 
achieve the ring expansion. In principle, when 8 is generated, two possible bond fissions 
can occur (Scheme 7). One is the exo-fission, furnishing 9, the other is the desired 
endo-fission, generating 10. Different reaction conditions gave products with different 
types of bond fissions. For example, Murai group reported exo-fission of cyclopropanol 
trimethylsilyl ether 11 when treated with oxidizing agent AgBF4 or Cu(BF4)2, and 
subsequent dimerization gave compound 12.16 On the other hand, Saegusa reported an 
endo-fission of cyclopropanol trimethylsilyl ethers when subjected to FeCl3 in DMF by a 
radical pathway (Scheme 8).17 The Saegusa procedure seemed to fit the requirement of 
the tricholomalide synthesis, and was followed on substrate 8. Unfortunately, 9, from 
exo-fission, was the major product. Slight variation of the Saegusa procedure neither 
provides improvement of the yield nor reverses the ratio of product distribution. 
 
                                                            
14 Piers, E.; Renaud, J.; Rettig, S. J. Synthesis 1998, 590 - 602. 
15 Duhamel, P.; Dujardin, G.; Hennequin, L.; Poirier, J.-M. J. Chem. Soc., Perkin Trans. 1 1992, 387 – 396. 
16 Ryu, I.; Ando, M.; Ogawa, A.; Murai, S.; Sonoda, N. J. Am. Chem. Soc. 1983, 105, 7192 – 7193. 
17 Ito, Y.; Fujii, S.; Saegusa, T. J. Org. Chem. 1976, 41, 2073 – 2074. 
11 
Scheme 7. Two Fission Modes Leading to Different Ring Systems 
 
Scheme 8. Murai’s and Saegusa’s Examples Showing Different Fission Modes 
 
To move forward, other ring expansion methods should be explored. A non-oxidative 
ring expansion pathway attracted our attention. Stork reported a vinyl acetate (part of a 
steroid) was cyclopropanated by dichlorocarbene, and during hydrolysis of the acetate 
ester of cyclopropanol, a ring expansion occurred and α-chloro-α,β-unsaturated 
cycloheptanone derivative was obtained.18 Conia also reported a chloromethylcarbene 
                                                            
18 Stork, G.; Nussim, M.; August, B. Tetrahedron, 1966, Suppl. 8, 105 – 112. 
12 
reacted with silyl enol ether and the resultant cyclopropyl silyl ether (mixtures of isomers 
as shown) underwent ring expansion upon heating or treatment with base.19  The 
ring-opening rates of the two isomers were different. And Wenkert disclosed 
cyclopropanation of silyl enol ether using dibromocarbene.20 All of the above methods 
provide additional possibility for functionalization of the B ring of tricholomalides, either 
introducing C19 methyl or set stages for other functional groups (Scheme 9). 
Scheme 9. Non-Oxidative Ring Expansion Pathway 
 
                                                            
19 (a) Blanco, L.; Amice, P.; Conia, J.-M. Synthesis, 1981, 289 – 291. (b) Slougui, N.; Rousseau, G.; Conia, J.-M. 
Synthesis, 1982, 58 – 60. 
20 Wenkert, E.; Arrhenius, T. S.; Bookser, B.; Guo, M.; Mancini, P. J. Org. Chem. 1990, 55, 1185 – 1193. 
13 
Indeed, the non-oxidative approach was quite successful. When silyl enol ether 13 was 
treated with chloromethylcarbene or dibromocarbene, the cyclopropanation occurred, and 
the resultant cyclopropyl silyl ether was subjected to Ag+, and the desired ring expansion 
gave dienones 16 or 17, respectively. Intermediate 17 was further reduced to 1021 (later I 
found 17 could be transformed into 16 by Negishi coupling). Compounds 10, 16, and 17 
should have different usage for the introduction of the lactone motif (Scheme 10). 
Scheme 10. Successful Ring Expansion 
 
Comparing the two ways of ring expansion in this case, it seems that the oxidative path 
favors exo-fission, while the non-oxidative path favors endo-fission. Stereoelectronic 
                                                            
21 Mandal, A. K.; Mahajan, S. W. Tetrahedron 1988, 44, 2293 – 2299. 
14 
effect and steric reason may account for the different selectivity. For example (Scheme 
11), in the oxidative pathway, when R1 = R2 = H, the indicated bent bond in 
cyclopropanol radical may hyperconjugate with the double bond, and might be more 
activated for exo-fission. However, in the non-oxidative path, the starting point was 
abstraction of halide by Ag+, and cyclopropyl cation (or with partial positive charge) may 
form, and pericyclic retro-electrocyclization (thus disfavoring vinyl migration) or 
electron pair rearrangement (favored by the ‘push-pull’ mechanism) finally gave the 
endo-fission product. Steric reasons, such as ring fusion and ring strains, may also play an 
important role in this case. 
Scheme 11. An Explanation for Different Fission Modes 
 
1.4.2 Attempts to introduce the C ring lactone moiety 
With the desired dienone in hand, the next task was to work on the quaternary carbon 
C5 (Scheme 12). The first attempt was to alkylate C5 in deconjugative manner using 
15 
methyl iodoacetate. However, we did not get the desired regioselectivity, and the γ-H on 
C12 was more acidic. So, regioselective deprotonation on C9 was the major task, and the 
bromo-dienone 17 seemed to be a reasonable starting point. Thus, methoxycarbonylation 
using palladium chemistry or Mander’s reagent was tried to introduce an ester group, but 
substrates such as 17, 19, and 20 were not amenable to those ester formation reactions 
(Scheme 12). So, although difficult to explain, the ester activating group might not be a 
intermediate easy to reach, and other functional groups were conceived and tried as 
alternatives. 
























R = H, 18
R = TMS, 19
R = SEM, 20
n-BuLi or t-BuLi, NCCOOMe
or [Pd], CO, MeOH RO
MeOOC
R = TMS, 21
R = SEM, 22  
16 
Because of Sun-Joon’s research experience on the α-alkynyl dienophiles,22 the alkynyl 
group was considered as a useful alternative instead of an ester group. The alkynyl group 
might have two advantages: first, it conjugated with Δ5,8 double bond, making the γ-H on 
C9 more acidic for the deconjugative alkylation (otherwise, the γ-H on C12 was more 
acidic, vide supra); second, it might serve as the lactone carbon chain. Fortunately, this 
time the alkynyl moiety was successfully introduced using Sonogashira cross coupling 
reactions, furnishing 23 and 24. However, although the activating ability of the alkynyl 
group was validated, deconjugative methylation was partially successful: the major 
product was 26 from O-methylation, and C-methylation product 27 was minor (with 
unkown stereochemistry at C5). This result was not surprising, because compound 26 had 
a fully conjugated triene system, and homo-aromaticity23 might favor the formation of 26, 
too (Scheme 13). 
Scheme 13. Alkynyl-Facilitated Deconjugative Alkylation 
 
                                                            
22 Min, S.-J.; Jones, G. O.; Houk, K. N.; Danishefsky, S. J. J. Am. Chem. Soc. 2007, 129, 10078 – 10079. 
23 Williams, R. V. Chem. Rev. 2001, 101, 1185 – 1204. 
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It seemed that building up C5 quaternary carbon stereoselectively needed other reliable 
ways, and intramolecular stereochemical induction would serve as good solution. Thus, 
dienone 16 was isomerized, furnishing 28, the carbonyl of 28 was reduced into alcohol, 
and different reducing conditions gave different preferences of the product distribution. 
Indeed, a cyclopropanation strategy set up C5 stereoselectively. Thus, the two alcohols 
were acylated and cyclopropanation was executed following the Corey-Myers protocol24 
or diazo transfer method. Mono-activated and di-activated cyclopropanes 31, 33, and 35 
were synthesized in this strategy. Luckily, compound 33 crystallized and X-ray 
crystallography confirmed all the relative stereochemistry (Scheme 14). 
Scheme 14. Building up C5 Using Cyclopropanation Protocol 
 
                                                            




  The next job was to unmask the double bond by cyclopropane opening.25 The 
mono-activated cyclopropane 31 was, not surprisingly, resistant to open. However, the 
di-activated cyclopropane 35 resisted ring opening except under harsh conditions. 
Various nucleophiles were screened, including chloride, iodide, alcohol, bromide, 
cyanide, sulfide, azide, selenide, etc, and only LiCl gave the desired ring-opening product 
36 in poor yield. The cyclopropane strategy was finally abandoned because 31 formed 
again when 36 was treated with base to eliminate HCl. 
Scheme 15. Cyclopropane Opening Attempts 
 
                                                            
25 Danishefsky, S. Acc. Chem. Res. 1979, 12, 66 – 72. 
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1.5 Successful Synthesis of C Ring Lactone 
  When I started this project, it seemed other methods should be utilized to install the 
lactone ring. Considering the cis-fusion of B-C ring system of tricholomalides, it might 
be possible to set up the C5 and C8 stereochemistry correctly at the same time, an 
approach that might actually reduce the difficulty in the synthetic sequence. However, 
one concern existed that in intermediates 29 and 30, two tri-substituted double bonds 
needed to be carefully differentiated. Since the C2 hydroxyl group was closer to the 
C5-C8 double bond, introduction of the lactone with the help of a tether made from the 
C2 hydroxyl was still my first choice. 
  Two proposals were conceived (Scheme 16). The first proposal was based on 
Weinreb’s hetero-Diels-Alder reaction between N-acyl imines and alkenes, and literature 
precedent had already provided useful examples for our intramolecular case. In detail, the 
glyoxylate could be transferred into the diene intermediate 37, and 
inverse-electron-demond Diels-Alder reaction would give the correct substitution on C5 
and C8. Further manipulation would result in the desired product 38.26 The second 
proposal was based on ketene-olefin [2+2] cycloaddition. The oxygen atom on C8 could 
be introduced simply by Baeyer-Villiger oxidation, thus a tethered ketene 39 was 
proposed and the [2+2] cycloaddition would be regio- and stereoselective. After 




26 (a) Scola, P. M.; Weinreb, S. M. J. Org. Chem. 1986, 51, 3250 – 3252. (b) Melnick, M. J.; Weinreb, S. W. J. Org. 
Chem. 1988, 53, 850 – 854. 
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Scheme 16. New Proposals for C Ring Lactone Installation 
 
The second proposal, ketene-olefin [2+2] cycloaddition, was tried first. The acyl 
ketene could be generated in several ways, one is the malonyl mono-chloride elimination, 
and another would employ Wolff rearrangement. Using the first method, malonate diester 
41 was obtained, and it was not clear if ketene formation occurred or not based on the 
product, but no desired cyclobutanone 40 was obtained. 
Scheme 16. Attempts for Tethered Ketene-Olefin [2+2]---(1) 
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It is known that the Wolff rearrangement generates an acyl ketene under palladium 
catalyst or photolysis. 27 , 28  The photolysis condition was attempted after the 
diazo-pyruvate 42 was made according to literature.29 Photolysis of diazo-pyruvate in 
benzene did not give the desired cyclobutanone 40, and when methanol was added as 
additional nucleophile, the mixed malonate diester was observed, as confirmed by NMR 
analysis (Scheme 17). 




























Then it was clear that the ketene 39 was definitely made, while the [2+2] did not 
happen. This led us to learn more about ketenes (Scheme 18). For ketene stability, the 
coefficients of the LUMO and HOMO of ketenes imply the substituent effect.30 Thus, 
                                                            
27 Bien, S.; Segal, Y. J. Org. Chem. 1977, 42, 1685 – 1688. 
28 Gallucci, R. R.; Jones, M., Jr. J. Org. Chem. 1985, 50, 4404 – 4405. 
29 Müller, P.; Chappellet, S. Hel. Chim. Acta 2005, 88, 1010 – 1021. 
30 (a) Houk, K. N.; Strozier, R. W.; Hall, J. A. Tetrahedron Lett. 1974, 15, 897 – 900. (b) Tidwell, T. T. Eur. J. Org. 
Chem. 2006, 563 – 576. (c) Tidwell, T. T. Acc. Chem. Res. 1990, 23, 273 – 279. (d) Tidwell, T. T. Ketene II (John 
Wiley & Sons, Inc.) 2006, 5 – 26. 
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strong σ-donors or π-acceptors stabilize the ketene functional group; on the other hand, 
substituents such as O, N, Cl, etc. would destabilize ketenes because (1) their lone pair 
electrons interact with the electron-negative C2 of ketenes and (2) the C-X (X = O, N, or 
Cl, etc.) bond is not a good σ-donor. In the literature, two possible mechanisms are used 
to describe ketene-olefin [2+2] cycloaddition, one is based on the Woodward-Hoffmann 
Rules, and the other relies on a zwitterionic intermediate.31 These two mechanisms are 
difficult to distinguish for many cases because of a similar alignment of cross-located 
cycloaddition partners. Hence two possibilities might account for the failure of tethered 
ketene-olefin [2+2] cycloaddition: first, the alkoxycarbonyl group was 
electron-withdrawing, stabilizing ketene 39; second, the tether made the cross-located 
alignment of ketene and Δ5,8 endo-cyclic olefin difficult to form simply because the tether 
was not long enough, although it was reported that exo-cyclic olefin was reactive 
intramolecularly.32 
Scheme 18. Ketenes’ FMO and Alignment of Ketene-Olefin [2+2] Cycloaddition 
 
To solve the reactivity and stereochemistry problem of ketene-olefin [2+2] 
cycloaddition, dichloroketene seemed to be a good alternative. Dichloroketene was 
                                                            
31 Tidwell, T. T. Ketene II (John Wiley & Sons, Inc.) 2006, 437 – 625. 
32 Corey, E. J.; Desai, M. C.; Engler, T. A. J. Am. Chem. Soc. 1985, 107, 4339 – 4341. 
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well-known in ketene-olefin [2+2] cycloaddition with privileged reactivity. The only 
concern was the chemo- and stereo-selectivity in substrates such as 30. Two double 
bonds, totaling four reactive faces had to be differentiated, and the desired 
diastereoselectivity must be reached by some means. Conceivably, if 29 were chosen as 
the substrate, a large protecting group might block the β-face of the two double bonds; 
and the α-face of the Δ11,12 double bond in A ring might also be less reactive towards 
dichloroketenes because of the steric interaction of C18 methyl and the incoming oxygen 
of dichloroketene. The olefin positions and torsional strains might all play a role to 
differentiate the reactivity of the two olefins. Overall, the α-face of the Δ5,8 double bond 
might be the most reactive face towards dichloroketene, which would give the desired 
product (Scheme 19). 








This proposed transformation worked very well using Mehta’s modified procedure to 
generate dichloroketene under sonication.33 Corey rationalized that the observed high 
diastereoselectivity resulted from stabilizing the zwitterionic intermediate by electrostatic 
and/or partial bonding interation between partially negative O on C2 and partially 
                                                            
33 Mehta, G.; Rao, H. S. P. Syn. Comm. 1985, 15, 991 - 1000. 
24 
positive C5. The overall success of the ketene-olefin [2+2] might involve both steric and 
electronic interactions. Preparation of lactone 47 was achieved under standard 
dechlorination, 34  Baeyer-Villiger oxidation, 35  and deprotection conditions in high 
yields (Scheme 20). The Weinreb’s N-acyl imine cycloaddition was not attempted at this 
stage. 
Scheme 20. Successful Synthesis of C Ring Lactone 
 
1.6 Total Synthesis of Tricholomalides A (1) and B (2) 
The next task was to append the C3, C4 and C20 hydroxyisopropenyl group of 
tricholomalides. Our original proposal of intramolecular Nozaki-Hiyama-Kishi (NHK) 
reaction was not tested at first. Looking into the close environment of the 
hydroxyisopropenyl, we proposed that Grignard addition to a C2 ketone would be a 
plausible straightforward approach, because the NHK reaction would require more steps 
for the late stage modification. Alcohol 47 had another advantage that the stereochemical 
                                                            
34 Blaszczyk, K.; Koenig, H.; Paryzek, Z. Eur. J. Org. Chem. 2005, 749 – 754. 
35 Nemoto, H.; Fujita, S.; Nagai, M.; Fukumoto, K.; Kametani, T. J. Am. Chem. Soc. 1988, 110, 2931 – 2938. 
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information of C2 could be transferred into C12 by hydroxyl-directed epoxidation, and 
the ‘saved’ stereochemical information on C12 could then be reverse-transferred back to 
C2 in the same manner, when making the originally proposed tricholomalides A (1’) and 
B (2’) was needed (vide infra). To advance the route, stereoselective epoxidation 
furnished 48, whose structure was confirmed by X-ray crystallography. Intermediate 48 
was oxidized and β-elimination afforded 49, which could be protected as TES ether 50 
that might also be useful for cross-coupling reactions to introduce the isopropenyl moiety 
(Scheme 21). 















R = H, 49
R = TES, 50, 84% from 48
TESCl,
i-Pr2NEt  
The Grignard addition, not surprisingly, was difficult because of both the congested 
environment and Δ1,11 double bond deactivation of C2 carbonyl. Nucleophilic addition 
attempts using the corresponding isopropenyllithium reagent were unsuccessful as well. 
Fortunately, isopropenylcerium dichloride worked, furnishing 51 in 31% - 66% yield 
after several attempts, and 10 equivalents of isopropenylmagnesium bromide and 15 
equivalents of CeCl3 were used to give the best results (Scheme 22).36 In retrospect, 
Knochel’s soluble LaCl3·2LiCl2 reagent might be a superior choice instead of CeCl3 for 
the Grignard addition.37 The stereochemistry of C2 in 51 was not known then and it had 
                                                            
36 Imamoto, T.; Takiyama, N.; Nakamura, K.; Hatajima, T.; Kamiya, Y. J. Am. Chem. Soc. 1989, 111, 4392 - 4398. 
37 Krasovskiy, A.; Kopp, F.; Knochel, P. Angew. Chem. Int. Ed. 2006, 45, 497 – 500. 
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been anticipated that the C19 angular methyl and the bulky C12 OTES group would 
prevent the organometallic reagent from approaching the β-face, giving the originally 
desired intermediate leading to compound 1’. The TES group of 51 was removed by mild 
HF-pyridine condition, while TBAF also generated a lactone transposition product 54, 
which might be useful towards the synthesis of tricholomoalide C and 
trichoaurantianolides. Intermediate 52 was further oxidized to 53 by MnO2. Surprisingly, 
X-ray crystallography of 53 showed that C2 stereochemistry resulted from β-face 
approach of the organometallic reagent, which was not the desired product. The 1H NMR 
was quite similar to the reported tricholomalide B except for the isopropenyl. With strong 
curiosity, I ran the allylic oxidation using SeO2, and an interesting product 2 was isolated, 
whose 1H NMR and 13C NMR were identical to the reported data for tricholomalide B. 
X-ray crystallography confirmed the structure of 2, although the assignment of the 
hydroxyisopropenyl was assisted by NMR because of disorders of that group in crystal. 









































  Interestingly, when 2 was treated with NaOMe in MeOH, aiming to furnish 
tricholomalide C (3) through translactonization, compound 1 was obtained, whose 1H 
NMR and 13C NMR were identical to those reported for tricholomalide A, and luckily, 
X-ray crystallography confirmed the structure assignment (Scheme 22). This Michael 
addition was similar to what Ohta group reported. In their experiment, tricholomalide B 
was transformed into tricholomalide A in DMSO at 4 .℃ 7 Taking tricholomalide C and 
trichoaurantianolides into consideration, we inferred that all the tricholomalides and 
trichoaurantianolides might share the same stereochemistry at C2. Thus, all the data 
strongly implied a possible structural misassignment by the Ohta group. 
Intermediate 51 resulted from addition syn to the C19 angular methyl. It was originally 
believed that the C19 methyl and C12 OTES group would block the top face. However, 
since the carbonyl was close to the cis-junction of B-C rings, this ring junction should 
play a pivotal role. Thus, the convex-face of B-C rings might be more accessible than the 
concave-face, which led to 51 through Grignard addition. 
1.7 Successful Synthesis of the Proposed Structure of Tricholomalide B (2’) 
  Because we were unable to obtain authentic samples of trcholomalides, our structural 
correction of tricholomalides A and B was not conclusive at that time. The possibility 
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existed that the synthetic compounds 1 and 2 indeed had the same 1H NMR and 13C NMR 
as the proposed structures of 1’ and 2’, respectively. To solve this problem, we decided to 
make a small amount of 1’ and/or 2’ for comparison.38  
To make the originally proposed structures of 1’ and 2’, the easiest way seemed to be a 
Mislow-Evans reaction that might convert 1 to 1’.39 The idea was based on the fact that 
Grignard reagent approached C2 from the convex-face of B-C ring system, so the 
thiophile might also break the S-O bond on the convex-face and ‘epimerize’ C2 
configuration. However, the desired sulfenate could not be made, and only 55 was 
obtained (Scheme 23). 
Scheme 23. Attempts of Mislow-Evans Transformation 
 
So we had to move back to search for other ways to make 1’ and/or 2’. The original 
proposal of functionalizing C1, C2, C11, and C12 involved installation of the isopropenyl, 
and using our ‘saved’ stereochemical information on C12, a hydroxyl-directed 
epoxidation would set up the C2 OH stereoselectively. This promising strategy was 
undertaken (Scheme 24). Luckily, when 50 was hydrogenated, a product with 
cis-junction of the A-B rings was obtained, and 56 was transferred into the allylic alcohol 
using CeCl3-mediated Grignard addition.36 However, dehydration of 57 failed to give the 
                                                            
38 The chemistry described below was not thoroughly optimized. 
39 Evans, D. A.; Andrews, G. C. Acc. Chem. Res. 1974, 7, 147 – 155. 
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desired diene 58 using Martin’s sulfurane or Burgess’ reagent, and the starting material 
57 was recovered. This implied that in 57 the OH on C2 was α, and thus was shielded by 
the C ring. An alternative approach would be making the corresponding triflate followed 
by cross-coupling reactions. When there was a triethylsiloxy group on C12, the triflation 
occurred at C7 lactone site, producing 60. This was probably because the silyl group was 
too large, and thus it prohibited the base from approaching the axial H on C1. To 
decrease the steric bulk of the protecting group, we decided to install a methoxymethyl 
group which might even coordinate the metal cation to further ease deprotonation. 
Scheme 24. Attempts to Make Diene 58 
 
Switching TES group into MOM on substrate 56 resulted in hemiketal formation, 
although some desired 63 could be obtained when treated with MOMCl and i-Pr2NEt. 
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Alternatively, we found that protecting 49 with MOMCl and subsequent hydrogenation 
would provide 63 stereoselectively. This time, triflation occurred at the C2 ketone, 
furnishing 65. Cross-coupling was performed in Corey-modified Stille protocol to give 
66, 40  and MOM deprotection was achieved under a mild condition developed by 
Ireland’s group,41 avoiding possible dehydration of the homo-allylic alcohol. The next 
epoxidation step required prudent execution because two double bonds and steric 
hindrance might scramble the regio- and stereoselectivity. So, VO(acac)2 mediated 
epoxidation would secure the stereoselectivity.42 In practice, this epoxidation method 
provided 43% yield of desired product 68. Furthermore, standard oxidation-epoxide 
opening sequence gave 69. The allylic oxidation finally gave 2’ in 16% yield. It was not 
surprising that when C2 hydroxyl was exposed to the convex-face of B-C rings, it would 
be more sensitive to acidic conditions. Fortunately, X-ray crystallography confirmed the 
structure of 2’ (Scheme 25). 
  The 1H NMR and 13C NMR of 2’ were clearly different from those reported for 
tricholomalide B. Thus, the structure of tricholomalide B was 2 as we luckily synthesized 
at first, rather than 2’. Furthermore, since tricholomalide B could be converted to 
tricholomalide A under mild conditions (in DMSO at 4 ℃) as the Ohta group reported, 
we inferred that the two natural products should share the same stereochemistry at C2. 
Thus, the structure of tricholomalide A should be 1, rather than 1’. Further support of our 
revised structure of tricholomalide A include: (1) NOE of 1 matched the assignment by 
the Ohta group on the stereochemistry of C11 and C1; (2) computational chemistry 
                                                            
40 Han, X. J.; Stoltz, B. M.; Corey, E. J. J. Am. Chem. Soc. 1999, 121,7600–7605. 
41 Ireland, R. E.; Varney, M. D. J. Org. Chem. 1986, 51, 635-648. 
42 Mihelich, E. D.; Daniels, K.; Eickhoff, D. J. J. Am. Chem. Soc. 1981, 103, 7690-7692. 
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support by Prof. Goodman at University of Cambridge.43 Interestingly, the B-D rings 
share a trans-junction, different from trichoaurantianolides C and D, while the A-B rings 
are cis-fused, this might show some thermodynamic control in the cyclization step. 
Scheme 25. Total Synthesis of Originally Proposed Tricholomalide B (2’) 
 
                                                            
43 Smith, S. G.; Goodman, J. M. J. Am. Chem. Soc. 2010, 132, 12946 – 12959. 
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1.8 Conclusion 
  In summary, the total synthesis of (±)-tricholomalides A and B were achieved in 22 
and 21 steps, respectively, from commercially available 2-methyl-2-cyclopentenone. The 
homo-Robinson approach was investigated, and it led to the setup of the A-B rings with 
useful functional group distribution. A ketene-olefin [2+2] cyclization provided the 
desired C ring lactone precursor with high yield and stereoselectivity. A CeCl3-based 
Grignard addition installed the isopropenyl group and led to the correct structure of 
tricholomalide B. We have shown that tricholomalide A is selectively prepared by simply 
treating tricholomalide B with NaOMe in MeOH. In addition, the synthesis of originally 
proposed structure (2’) of tricholomalide B confirmed our re-assignment of both 
tricholomalides A and B. Since asymmetric synthesis of 7 was achieved,11c our synthetic 
route would provide substantially enantiopure tricholomalides A and B. And the 
experiences and findings during this endeavor set stage for the syntheses of 











Unless mentioned otherwise, all non-aqueous reactions were carried out in 
vacuum-flame-dried glasswares under a balloon-pressure of argon; reagents were 
commercially available and used as received; anhydrous solvents were purchased as the 
highest grade from Sigma-Aldrich, or passed through a solvent-purification system, or 
purified as following: THF was distilled from Na-benzophenone, CH2Cl2 was distilled 
from CaH2. Reactions were monitored by thin-layer chromatography on Merck silica gel 
60-F254 coated 0.25 mm plates. Flash column chromatography was performed using 
RediSep® pre-packed disposable silica gel columns (normal phase, 230-400 mesh) from 
Teledyne Isco. And prep-TLC was performed on Merck silica gel 60-F254 coated 0.50 or 
1 mm plates. Yields were reported as isolated, spectroscopically pure compounds. And 
NMR spectra were obtained on Bruker DRX 300, or 400 MHz, or Bruker DMX 500 MHz 
spectrometers. CDCl3, dried by standing over K2CO3, was used and chemical shifts were 
referenced on residual solvent peaks (δ = 7.26 for 1H NMR and 77.00 for 13C NMR). 
Abbreviations for 1H NMR: s = singlet, d = doublet, t = triplet, q = quartlet, m = multiplet, 
or br = broad. IR spectra were obtained on a Perkin-Elmer Paragon 1000 FTIR 
spectrometer. And high resolution mass spectra were acquired from Columbia University 
Mass Spectral Core facility on a JEOL HX110 spectrometer or from Memorial 
Sloan-Kettering Cancer Center on a Perkin-Elmer Sciex API 100 in ionspray mode. 






  To a stirred solution of 28 (2.18 g, 10.0 mmol) in 30 mL DCM was added 12 mL 
DIBAL-H (1.0 M in hexanes) at -78 , and the reaction mixture was kept at that ℃
temperature for 1 h before quenched by a small amount of NH4Cl (sat.), then slowly 
warmed up to room temperature. MgSO4 was added and the slurry was vigorously stirred 
for 1 h. The drying agent was filtered and the filtrate was evaporated under reduced 
pressure, and flash column chromatography (hexanes:EA=19:1 to 9:1) first gave 29 (1.41 
g, 6.4 mmol, 64% yield) and then 30 (0.38 g, 1.7 mmol, 17% yield). Analytical data of 29 
and 30 were identical to our previous report.1a 
 
 
  To a stirred solution of 30 (383 mg, 1.74 mmol) in 5 mL DCM was added Dess-Martin 
Periodinane (837 mg, 1.92 mmol) in several portions at room temperature. 20 min later, 
Et2O was added and the solid was filtrated off. The filtrate was concentrated and 
redissolved in Et2O and filtered. The solution was evaporated under reduced pressure and 
                                                            
44 Procedures before 29 were reported in ref. 1(a). 
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the residue was subjected to prep-TLC (hexanes:EA=6:1) and gave the desired product 
28 (299 mg, 1.37 mmol), 79% yield. 
 
 
  To a stirred solution of 29 (108 mg, 0.49 mmol) in 2 mL DCM was added 0.21 mL 
Et3N (149 mg, 1.47 mmol), and cooled to 0 . 0.20 mL TIPSOTf ℃ (227 mg, 0.74 mmol) 
was added dropwise, and then the whole solution was warmed up to r.t. and stirred for 2 h. 
NaHCO3 (sat.) was added, followed by hexanes, and two layers were separated and the 
organic layer was washed by brine, dried over MgSO4, the drying agent was filtrated and 
the filtrate was evaporated under reduced pressure, and flash column chromatography 
(hexanes) gave the desired product 43 (164.6 mg, 0.44 mmol), 89% yield. 
1H NMR (400 MHz, CDCl3): δ 5.45 (td, J = 7.6, 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 
4.56 (dd, J = 8.0, 5.2 Hz, 1H), 2.53 – 2.43 (m, 2H), 2.39 (dd, J = 14.4, 8.0 Hz, 1H), 2.27 
– 2.18 (m, 1H), 1.97 (dd, J = 14.4, 8.0 Hz, 1H), 1.89 – 1.79 (m, 1H), 1.76 (d, J = 0.8 Hz, 
3H), 1.78 – 1.68 (m, 1H), 1.56 (dt, J = 9.6, 8.0 Hz, 1H), 1.15 – 0.97 (m, 24H), 0.94 – 0.85 
(m, 6H); 13C NMR (100 MHz, CDCl3): δ 149.06, 142.31, 124.52, 121.92, 70.78, 56.43, 
48.91, 37.82, 35.90, 34.84, 29.62, 23.40, 22.83, 21.00, 18.10, 18.09, 17.83, 12.41; IR 
(NaCl, cm-1): 2944, 2892, 2867, 1683, 1463, 1384; HR-MS (FAB+) calcd for C24H43OSi 
(M-1): 375.3083, found 375.3109. 
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  Compound 43 (2.62 g, 6.96 mmol) was dissolved in 30 mL Et2O in a round-bottom 
flask, and Zn powder (3.64 g, 55.7 mmol) was added. The flask was immersed in a 
sonicator and 3.89 mL CCl3COCl (6.33 g, 34.8 mmol) in 20 mL Et2O was added 
dropwise under sonication. 5 min later, the whole slurry was filtrated through a thick pad 
of silica gel and the residue was washed by Et2O twice. The filtrate was evaporated and 
flash column chromatography (hexanes) gave the desired product 44 which was 
immediately used in the next step. 
1H NMR (400 MHz, CDCl3): δ 5.39 (q, J = 2.0 Hz, 1H), 4.96 (dd, J = 10.4, 7.6 Hz, 1H), 
2.90 – 2.80 (m, 2H), 2.47 (dd, J = 14.8, 10.4 Hz, 1H), 2.31 (ddt, J = 16.0, 8.4, 2.8 Hz, 
1H), 2.05 – 1.98 (m, 2H), 1.87 (dq, J = 14.4, 3.2 Hz, 1H), 1.74 – 1.63 (m, 1H), 1.51 (dt, J 
= 9.6, 8.0 Hz, 1H), 1.33 (s, 3H), 1.20 – 1.05 (m, 21H), 1.02 (s, 3H), 0.97 (d, J = 6.4 Hz, 
3H), 0.88 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 199.53, 145.34, 127.04, 
92.71, 69.84, 61.46, 53.71, 50.78, 49.86, 38.52, 36.61, 35.61, 29.60, 23.04, 22.57, 20.09, 
18.68, 18.40, 18.35, 13.08; IR (NaCl, cm-1): 2946, 2868, 1805, 1463, 1385; HR-MS 














44 45  
  44 was dissolved in 100 mL HOAc, and Zn powder (3.67 g, 56.1 mmol) was added, 
and the stirred slurry was heated at 100  for 3.5 h, and then cooled down. Zn powder ℃
was filtrated through a thick pad of silica gel and the filtrate was evaporated. The residue 
was dissolved in Et2O and washed by NaHCO3 (sat.) and brine. The organic phase was 
evaporated under reduced pressure and directly subjected to the next step. 
1H NMR (500 MHz, CDCl3): δ 5.33 (s, 1H), 4.40 (dd, J = 9.5, 7.5 Hz, 1H), 3.04 (dd, J = 
18.5, 3.0 Hz, 1H), 2.88 – 2.79 (m, 1H), 2.76 – 2.62 (m, 2H), 2.45 (dd, J = 15.0, 10.0 Hz, 
1H), 2.30 (dd, J = 16.0, 8.0 Hz, 1H), 1.93 – 1.85 (m, 2H), 1.72 – 1.62 (m, 2H), 1.58 (dd, J 
= 18.0, 10.0 Hz, 1H), 1.25 (s, 3H), 1.12 – 1.01 (m, 21H), 1.00 – 0.92 (m, 6H), 0.88 (d, J = 
6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 214.13, 147.14, 126.06, 72.79, 63.32, 57.81, 
53.31, 49.60, 36.85, 36.40, 35.80, 35.74, 29.61, 23.14, 22.69, 20.44, 20.26, 18.25, 12.83; 
IR (NaCl, cm-1): 2919, 2849, 1780, 1457; HR-MS (FAB+) calcd for C26H47O2Si (M+1): 




  45 was dissolved in 20 mL THF, and 4.20 mL 10% aq. NaOH was added dropwise at 
0 , followed by dropwise addition of 2.80 mL 70% aq. TBHP. The whole solution was ℃
stirred for 2 h at 0 ℃ and then quenched by NaHSO3 (sat.), and neutralized by HCl (1M). 
The aqueous solution was extracted with Et2O (3×), and the combined organic phase was 
washed with brine and dried over MgSO4, the drying agent was filtrated and the filtrate 
was concentrated under reduced pressure. The residue was used directly without further 
purification. 
1H NMR (400 MHz, CDCl3): δ 5.38 (d, J = 2.0 Hz, 1H), 4.33 (dd, J = 11.2, 6.4 Hz, 1H), 
4.14 (dd, J = 12.8, 2.0 Hz, 1H), 2.70 – 2.55 (m, 2H), 2.45 (dd, J = 15.6, 11.2 Hz, 1H), 
2.39 – 2.30 (m, 2H), 1.99 (dd, J = 14.0, 2.0 Hz, 1H), 1.93 – 1.83 (m, 1H), 1.80 – 1.65 (m, 
3H), 1.15 – 0.98 (m, 30H), 0.91 (d, J = 5.6 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 
176.01, 144.20, 126.34, 84.46, 73.39, 55.02, 48.09, 46.05, 42.25, 41.02, 35.72, 35.49, 
29.59, 23.07, 22.55, 19.96, 19.47, 18.27, 12.87; IR (NaCl, cm-1): 2943, 2868, 1783, 1463; 
HR-MS (FAB+) calcd for C26H47O3Si (M+1): 435.3294, found 435.3300. 
 
 
  46 (from last step) was dissolved in 50 mL THF, and 42 mL TBAF (1.0 M, 42 mmol) 
was added. The reaction mixture was stirred at r.t. overnight and quenched by NH4Cl 
(sat.), the aqueous solution was extracted with Et2O (3×) and the combined organic phase 
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was washed with brine and dried over MgSO4, and the drying agent was filtrated and the 
filtrate was concentrated under reduced pressure, flash column chromatography 
(hexanes:EA=2:1) gave the desired product 47 (1.65 g, 5.94 mmol), 85% yield for 4 
steps. 
1H NMR (400 MHz, CDCl3): δ 5.34 (d, J = 2.0 Hz, 1H), 4.15 – 4.07 (m, 2H), 2.79 (s br, 
1H), 2.68 – 2.57 (m, 2H), 2.42 – 2.26 (m, 3H), 1.97 – 1.60 (m, 5H), 1.08 (s, 3H), 1.03 – 
0.92 (m, 6H), 0.86 (d, J = 6.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 176.40, 143.87, 
126.27, 84.81, 71.70, 54.86, 48.05, 44.89, 41.60, 40.72, 35.49, 34.72, 29.40, 22.97, 22.40, 
19.66, 19.09; IR (cm-1, NaCl): 2956, 2926, 2852, 1757; LR-MS (FAB+) calcd for 
C17H27O3 (M+1): 279.20, found 279.24. 
 
 
  47 (1.65g, 5.94 mmol) was dissolved in 30 mL DCM, and 77% mCPBA (2.66 g, 11.9 
mmol) was added by several portions. And the whole solution was stirred at r.t. over 
night. NaHCO3 (sat.) was added, followed by Et2O and about 5 mL Et3N, and the two 
layers were separated and the organic layer was washed with brine, dried over MgSO4, 
the drying agent was filtrated and the filtrate was evaporated under reduced pressure. 
Flash column chromatography (hexanes:EA=2:1) gave the desired product 48 (1.63 g, 
5.54 mmol), 93% yield. 
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1H NMR (400 MHz, CDCl3): δ 4.79 (dd J = 12.8, 2.8 Hz, 1H), 4.12 (s br, 1H), 3.15 – 
3.04 (m, 2H), 2.67 – 2.53 (m, 2H), 2.31 (d, J = 18.4 Hz, 1H), 2.10 – 1.98 (m, 2H), 1.58 (t, 
J = 13.6 Hz, 1H), 1.52 – 1.38 (m, 2H), 1.30 – 1.13 (m, 5H), 0.93 (s, 3H), 0.86 (d, J = 6.4 
Hz, 3H), 0.79 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 176.65, 83.66, 71.65, 
67.79, 58.35, 48.86, 45.12, 41.94, 41.36, 39.22, 34.96, 32.05, 28.82, 22.75, 22.23, 19.23, 
18.86; IR (NaCl, cm-1): 3443, 2963, 2924, 2873, 1763, 1747, 1456, 1438, 1381, 1198; 




  48 (1.63 g, 5.54 mmol) was dissolved in 100 mL DCM, and Dess-Martin periodinane 
(2.82 g, 6.65 mmol) was added in several portions, 20 min later, Et2O was added and the 
solid was filtrated off. The filtrate was concentrated and redissolved in Et2O and filtered. 
The solution was evaporated under reduced pressure and dried under vacuum. 
  The residual oil was redissolved in 40 mL DCM, and 2.61 mL i-Pr2NEt was added, the 
epoxide opening reaction completed within 0.5 h, furnishing 49. A small amount of 
solution was evaporated for analytical data of 49. 
Compound 49: 1H NMR (500 MHz, CDCl3): δ 6.06 (d, J = 2.0 Hz, 1H), 4.69 (d, J = 9.0 
Hz, 1H), 4.43 (dd, J = 9.5, 1.0 Hz, 1H), 3.16 (d, J = 18.5 Hz, 1H), 2.40 – 2.32 (m, 2H), 
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2.13 – 2.06 (m, 1H), 1.98 – 1.81 (m, 4H), 1.72 – 1.65 (m, 1H), 1.41 (s, 3H), 1.04 (d, J = 
6.5 Hz, 3H), 1.01 (s, 3H), 0.95 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 
203.83, 174.69, 166.05, 119.68, 81.38, 70.78, 57.85, 48.26, 46.97, 39.19, 36.86, 36.13, 
29.23, 25.32, 23.71, 23.34, 22.10; IR (NaCl, cm-1): 3439, 2962, 2923, 2873, 2851, 1779, 
1682, 1461, 1381, 1297, 1202, 1174; HR-MS (FAB+) calcd for C17H24O4: 292.1675, 
found 292.1665. 
  The resultant solution was combined with another 15 mL i-Pr2NEt and 12 mL TESCl. 
The reaction solution was stirred at r.t. for 3 days. NaHCO3 (sat.) was added, followed by 
Et2O, and the two layers were separated and the organic layer was washed with brine, 
dried over MgSO4, the drying agent was filtrated and the filtrate was evaporated under 
reduced pressure. Flash column chromatography (hexanes:EA=10:1) gave the desired 
product 50 (1.88 g, 4.63 mmol), 84% yield from 48. 
Compound 50: 1H NMR (400 MHz, CDCl3): δ 5.95 (d, J = 2.0 Hz, 1H), 4.63 (m, 1H), 
4.44 (d, J = 11.2 Hz, 1H), 3.12 (d, J = 18.0 Hz, 1H), 2.40 – 2.30 (m, 2H), 2.06 – 1.80 (m, 
4H), 1.71 – 1.62 (m, 1H), 1.41 (s, 3H), 1.06 – 0.92 (m, 18H), 0.63 (q, J = 8.0 Hz, 6H); 
13C NMR (100 MHz, CDCl3): δ 204.38, 174.84, 165.98, 118.81, 81.08, 70.55, 57.97, 
47.72, 46.16, 39.49, 37.11, 36.10, 29.54, 25.52, 23.98, 23.27, 22.12, 6.82, 4.82; IR (NaCl, 
cm-1): 2957, 2876, 1787, 1689, 1459, 1378, 1063, 1009; HR-MS (FAB+) calcd for 




  CeCl3‧7H2O (187.6 mg, 0.50 mmol, 99.999% purity, from Sigma - Aldrich) was dried 
under high vacuum at 150  overnight, and cooled to 0 , 3 mL THF (distilled from ℃ ℃
Na-benzophenone) was added, the slurry was stirred for 2.5 h at room temperature before 
cooled to -78 .℃  0.66 mL isopropenylmagnesium bromide (0.5 M in THF) was added 
dropwise, and the whole slurry was stirred for 1.5 h at the same temperature. 50 (12.3 mg, 
0.030 mmol, dissolved in 2 mL THF) was added dropwise, and stirred for 1 h. The 
mixture was quenched with 0.3 mL NaHCO3 (sat.) and then slowly warmed to r.t. Et2O 
was added, and the aqueous layer was separated and re-extracted with Et2O. The 
combined Et2O solution was washed with brine and dried over MgSO4. The residue after 
concentration was chromatographed by prep-TLC (hexanes:EA = 5:1) to give 9.0 mg 51 
(0.020 mmol), 66% yield. 
1H NMR (500 MHz, CDCl3): δ 6.19 (d, J = 1.5 Hz, 1H), 5.17 (s, 1H), 5.08 (s, 1H), 4.61 – 
4.52 (m, 1H), 4.00 (dd, J = 12.5, 2.0 Hz, 1H), 3.43 (d, J = 17.5 Hz, 1H), 2.70 (t, J = 13.5 
Hz, 1H), 2.06 – 2.00 (m, 2H), 1.94 – 1.80 (m, 5H), 1.75 – 1.67 (m, 2H), 1.64 (s, 1H), 1.06 
– 0.94 (m, 18H), 0.91 (d, J = 6.5 Hz, 3H), 0.61 (m, 6H); 13C NMR (75 MHz, CDCl3): δ 
177.29, 158.19, 149.27, 122.42, 114.65, 85.87, 75.20, 72.37, 49.74, 49.01, 44.98, 36.76, 
36.01, 35.52, 28.64, 25.49, 24.04, 23.21, 21.69, 21.62, 6.91, 4.95; IR (NaCl, cm-1): 3455, 
2957, 2876, 1760, 1458, 1191, 1070, 1001; HR-MS (FAB+) calcd for C26H45O4Si (M+1): 
449.3087, found 449.3097. 
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  0.10 mL HF-py (70%-30%) was added to 1 mL THF, and the solution was cooled to 
0 . ℃ 51 (23.1 mg, 0.052 mmol) in 3 mL THF was added dropwise. After stirring for 15 
min at 0 , NaHCO℃ 3 (sat.) was added dropwise, and the reaction mixture was warmed to 
r.t. Et2O was added, and the aqueous layer was separated and re-extracted with Et2O. The 
combined Et2O solution was washed with brine and dried over MgSO4. The residue after 
concentration was chromatographed by prep-TLC (hexanes:EA = 3:2) to give 13.8 mg 52 
(0.041 mmol), 80% yield. 
1H NMR (500 MHz, CDCl3): δ 6.30 (s, 1H), 5.20 (s, 1H), 5.11 (s, 1H), 4.54 (d, J = 8.5 
Hz, 1H), 3.95 (dd, J = 12.5, 2.0 Hz, 1H), 3.43 (d, J = 17.5 Hz, 1H), 2.67 (t, J = 13.5 Hz, 
1H), 2.07 – 2.01 (m, 2H), 1.98 – 1.87 (m, 4H), 1.85 – 1.68 (m, 4H), 1.07 – 1.00 (m, 9H), 
0.92 (d, J = 6.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 177.16, 159.09, 148.81, 123.62, 
114.95, 85.92, 75.16, 72.54, 50.03, 48.81, 45.80, 36.45, 35.97, 35.43, 28.25, 25.53, 24.11, 
22.78, 21.70, 21.59; IR (cm-1, NaCl): 3421, 2959, 2926, 1756, 1458, 1367, 1349, 1194, 




  52 (13.8 mg, 0.041 mmol) was dissolved in 1 mL THF, and 100 mg MnO2 was added. 
The whole slurry was stirred at r.t. overnight. The reaction mixture was filtered through a 
pad of silica gel. The filtrate was evaporated and the residue was subjected to prep-TLC 
(DCM:MeOH = 20:1) to give the desired product 53 (7.0 mg, 0.021 mmol), 51% yield. 
1H NMR (400 MHz, CDCl3): δ 7.11 (s, 1H), 5.27 (s, 1H), 5.18 (d, J = 1.2 Hz, 1H), 3.91 
(dd, J = 12.8, 2.4 Hz, 1H), 3.45 (d, J = 17.2 Hz, 1H), 2.73 (dd, J = 14.0, 12.8 Hz, 1H), 
2.47 (dd, J = 18.8, 7.6 Hz, 1H), 2.23 – 2.12 (m, 2H), 2.06 (d, J = 16.8 Hz, 1H), 1.98 – 
1.92 (m, 4H), 1.91 – 1.77 (m, 2H), 1.16 (s, 3H), 1.10 (d, J = 6.8 Hz, 3H), 1.04 (s, 3H), 
0.98 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 206.29, 176.32, 149.95, 147.55, 
133.15, 115.93, 85.22, 75.33, 48.76, 47.39, 44.20, 39.27, 36.82, 35.07, 28.55, 25.32, 
24.13, 22.17, 21.89, 21.56; IR (NaCl, cm-1): 3446, 2962, 2926, 2876, 1775, 1722, 1639, 
1457, 1387, 1192, 1000; m.p.: 203 – 208 (decompose); HR℃ -MS (FAB+) calcd for 
C20H28O4 (M+1): 333.2066, found 333.2065. 
 
 
  SeO2 (4.7 mg, 0.042 mmol) was added to 0.5 mL DCM and 0.10 mL TBHP (5.5 M in 
decane), then pyridine (3 drops by syringe needle, approximately 0.014 mL) was added. 
The mixture was stirred for 1 h before 53 (7.0 mg, 0.021 mmol) in 1 mL DCM was added. 
The reaction mixture was stirred at r.t. for 4 days. The reaction was quenched by adding 
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NaHCO3 (sat.) and Na2S2O3 (10% aq.). Then Et2O was added, and the aqueous layer was 
separated and re-extracted with Et2O. The combined Et2O solution was washed with brine 
and dried over MgSO4. The residue after concentration was chromatographed by 
prep-TLC (hexanes:EA = 1:2) to give 3.9 mg 2 (0.011 mmol), 53% yield. 
1H NMR (400 MHz, CDCl3): δ 6.95 (s, 1H), 5.53 (s, 1H), 5.43 (s, 1H), 4.30 (d, J = 12.0 
Hz, 1H), 4.22 (d, J = 12.0 Hz, 1H), 3.95 (dd, J = 12.8, 2.0 Hz, 1H), 3.89 (s br, 1H), 3.50 
(d, J = 16.8 Hz, 1H), 2.79 (t, J = 13.2 Hz, 1H), 2.48 (dd, J = 19.2, 8.0 Hz, 1H), 2.23 – 
2.12 (m, 2H), 1.99 (d, J = 16.8 Hz, 1H), 1.92 – 1.76 (m, 2H), 1.19 (s, 3H), 1.10 (d, J = 6.4 
Hz, 3H), 1.02 (s, 3H), 0.98 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 206.40, 
176.20, 149.34, 148.61, 135.02, 119.51, 85.53, 75.93, 65.87, 48.41, 47.40, 44.28, 39.35, 
36.81, 35.11, 28.57, 25.54, 24.14, 21.90; IR (NaCl, cm-1): 3393, 2958, 2925, 2873, 2852, 
1773, 1718, 1636, 1458, 1198, 1003; m.p.: 188 – 191 ; HR℃ -MS (FAB+) calcd for 
C20H29O5 (M+1): 349.2015, found 349.2010. 
 
 
  2 (3.6 mg, 0.010 mmol) was dissolved in 1 mL MeOH, and 0.5 mL NaOMe (0.5 M in 
MeOH) was added. The reaction mixture was stirred at r.t. overnight. NH4Cl (sat.) was 
added, followed by Et2O. The aqueous layer was separated and re-extracted with Et2O. 
The combined Et2O solution was washed with brine and dried over MgSO4. The residue 
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after concentration was chromatographed through a pipet column (DCM:MeOH = 40:1) 
to give 2.6 mg 1 (0.007 mmol), 72% yield. 
1H NMR (500 MHz, CDCl3): δ 5.24 (s, 1H), 5.16 (s, 1H), 4.51 (d, J = 13.5 Hz, 1H), 4.45 
(d, J = 11.5 Hz, 1H), 4.06 (d, J = 13.5 Hz, 1H), 3.82 (d, J = 11.5 Hz, 1H), 3.64 (d, J = 
17.0 Hz, 1H), 2.62 (dd, J = 19.5, 9.0 Hz, 1H), 2.50 (d, J = 11.0 Hz, 1H), 2.43 (dd, J = 
14.5, 12.5 Hz, 1H), 2.28 – 2.12 (m, 3H), 2.08 – 2.00 (m, 2H), 1.85 – 1.77 (m, 1H), 1.31 (s, 
3H), 1.10 (d, J = 6.5 Hz, 3H), 1.01 (s, 3H), 0.96 (d, J = 6.5 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 216.02, 175.86, 154.48, 109.45, 84.41, 80.44, 78.68, 71.90, 61.57, 46.42, 44.25, 
42.72, 40.22, 38.49, 35.07, 29.06, 25.39, 24.39, 23.31, 22.78; IR (NaCl, cm-1): 3375, 
2958, 2925, 2853, 1773, 1736, 1665, 1463, 1379, 1197, 1001; m.p.: 194 – 197  ℃
(decompose); HR-MS (FAB+) calcd for C20H29O5 (M+1): 349.2015, found 349.2013. 
 
 
  To a stirred solution of 49 (186.2 mg, 0.638 mmol) in 8 mL DCM were added 2.00 mL 
i-Pr2NEt and 0.50 mL MOMCl, and the reaction mixture was stirred overnight, quenched 
with aq. NaHCO3 (sat.). The organic layer was washed with brine and dried over MgSO4. 
Flash column chromatography (hexane:EA = 2:1) gave the desired product 63. 
Compound 63: 1H NMR (500 MHz, CDCl3): δ 6.05 (d, J = 2.0 Hz, 1H), 4.74 (d, J = 7.0 
Hz, 1H), 4.66 (d, J = 7.0 Hz, 1H), 4.61 – 4.55 (m, 1H), 4.43 (dd, J = 11.0, 1.0 Hz, 1H), 
47 
3.40 (s, 3H), 3.16 (d, J = 18.0 Hz, 1H), 2.40 – 2.32 (m, 2H), 2.04 – 1.86 (m, 4H), 1.72 – 
1.64 (m, 1H), 1.42 (s, 3H), 1.04 (d, J = 6.5 Hz, 3H), 1.01 (s, 3H), 0.94 (d, J = 7.0 Hz, 3H); 
13C NMR (125 MHz, CDCl3): δ 203.92, 174.69, 163.36, 119.96, 95.75, 81.27, 74.84, 
57.88, 55.78, 48.39, 46.57, 39.08, 36.05, 33.98, 29.25, 25.33, 23.81, 23.33, 22.09; IR 
(NaCl, cm-1): 2962, 2887, 1785, 1686, 1460, 1380, 1296, 1203, 1168, 1149, 1032, 1005; 
HR-MS (FAB+) calcd for C19H29O5 (M+1): 337.2015, found 337.1994. 
  63 was dissolved in 15 mL EtOAc, and 53.2 mg 10% Pd-C was added. The reaction 
mixture was degassed and refilled with H2 balloon three times. The reaction mixture was 
left overnight. Pd-C was filtered off and washed with EtOAc. The EtOAc solution was 
evaporated to furnish 65 (191 mg, 0.565 mmol) in 89% yield for 2 steps. 
Compound 65: 1H NMR (500 MHz, CDCl3): δ 4.68 (d, J = 11.0 Hz, 1H), 4.58 (d, J = 7.0 
Hz, 1H), 4.54 (d, J = 7.0 Hz, 1H), 4.19 (m, 1H), 3.33 (s, 3H), 2.66 (dd, J = 12.5, 12.0 Hz, 
1H), 2.48 (dd, J = 12.0, 3.0 Hz, 1H), 2.07 – 1.95 (m, 3H), 1.93 – 1.85 (m, 1H), 1.82 – 
1.75 (m, 1H), 1.69 (dd, J = 15.5, 11,5 Hz, 1H), 1.65 – 1.57 (m, 1H), 1.45 (s, 3H), 1.01 (d, 
J = 6.5 Hz, 3H), 0.95 – 0.89 (m, 6H); 13C NMR (125 MHz, CDCl3): δ 210.36, 174.63, 
95.68, 81.80, 76.16, 55.61, 55.58, 54.89, 46.38, 44.77, 41.64, 36.34, 35.81, 35.25, 29.67, 
24.93, 23.79, 23.07, 22.61; IR (cm-1, NaCl): 2958, 1782, 1711, 1462, 1383, 1040; IR 
(NaCl, cm-1): 2958, 1782, 1711, 1462, 1151, 1040; HR-MS (FAB+) calcd for C19H31O5 




  63 (87.5 mg, 0.26 mmol) in 7 mL THF was cooled to -78 , and 0.68 mL KHMDS ℃
(0.5 M in toluene, 0.34 mmol) was added dropwise. The reaction mixture was stirred at 
that temperature for 10 min before slowly warmed to 0  for ℃ 1 h. 
N,N-Bis(trifluoromethylsulfonyl)-5-chloro-2-pyridylamine was added in one portion. 20 
min later, the reaction was quenched with aq. NH4Cl (sat.). Et2O and hexane was added, 
and the organic layer was further washed with brine, and dried over MgSO4. Flash 
column chromatography (hexanes:EA = 1:0 to 9:1) gave the desired product 65 (69.1 mg, 
0.147 mmol) in 57% yield. 
1H NMR (400 MHz, CDCl3): δ 5.72 (d, J = 6.0 Hz, 1H), 4.74 (d, J = 11.2 Hz, 1H), 4.70 
(d, J = 7.2 Hz, 1H), 4.57 (d, J = 7.2 Hz, 1H), 3.95 (m, 1H), 3.33 (s, 3H), 2.93 (d, J = 17.2 
Hz, 1H), 2.40 (dd, J = 10.0, 4.8 Hz, 1H), 2.34 (d, J = 17.2 Hz, 1H), 2.10 (dd, J = 13.2, 6.0 
Hz, 1H), 1.95 – 1.78 (m, 3H), 1.72 – 1.61 (m, 1H), 1.46 (s, 3H), 1.31 (td, J = 13.6, 3.6 Hz, 
1H), 1.04 (s, 3H), 1.00 (d, J = 6.4 Hz, 3H), 0.91 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 173.77, 152.71, 118.23 (q, J = 320 Hz), 116.56, 95.00, 81.51, 77.31, 55.67, 
53.67, 49.65, 48.31, 43.22, 41.50, 39.11, 35.33, 28.44, 27.69, 24.82, 23.33, 22.92; IR 
(NaCl, cm-1): 2956, 1788, 1407, 1047, 1212, 1142, 1033, 1004; HR-MS (FAB+) calcd for 




  In a vial containing 65 (69.1 mg, 0.147 mmol) were added successively 139 mg LiCl, 
291 mg CuCl, 51 mg Pd(PPh3)4, and 0.18 mL tributyl(isopropenyl)stannane, and 3 mL 
DMSO. The vial was degassed under vacuum and refilled with Ar, and left to stir with Ar 
bubbling for 20 min. The vial was capped and placed in a 60  oil bath for 1.5 h. It was ℃
then cooled to room temperature, and the slurry was poured into brine and Et2O was 
added. The aqueous layer was re-extracted with Et2O and the combined organic layer was 
washed with water and brine, and then dried over MgSO4. Flash column chromatography 
(hexanes:EA = 15:1) gave the desired product 66 (42.2 mg, 0.117 mmol) in 79% yield. 
1H NMR (400 MHz, CDCl3): δ 5.42 (d, J = 9.6 Hz, 1H), 4.90 (s, 1H), 4.82 (t, J = 6.4 Hz, 
1H), 4.72 – 4.65 (m, 2H), 4.55 (d, J = 6.8 Hz, 1H), 3.95 (t, J = 4.0 Hz, 1H), 3.33 (s, 3H), 
2.78 (d, J = 16.8 Hz, 1H), 2.38 (dd, J = 9.2, 5.2 Hz, 1H), 2.24 (d, J = 16.8 Hz, 1H), 2.02 
(dd, J = 13.2, 6.4 Hz, 1H), 1.94 – 1.80 (m, 5H), 1.70 – 1.60 (m, 1H), 1.42 (s, 3H), 1.41 – 
1.22 (m, 2H), 1.04 – 0.96 (m, 6H), 0.91 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): 
δ 176.14, 147.89, 146.83, 122.12, 114.99, 94.72, 84.58, 77.69, 56.21, 55.42, 50.43, 47.63, 
42.85, 41.49, 40.86, 35.24, 28.78, 27.38, 26.79, 26.05, 23.36, 23.04; IR (NaCl, cm-1): 
2956, 2931, 1780, 1456, 1035, 995; HR-MS (FAB+) calcd for C22H35O4 (M+1): 




  66 (38.0 mg, 0.105 mmol) was dissolved in 2.7 mL acetonitrile containing 0.2 mL 
water, and the solution was heated at 72  overnight. The reaction mixture was cooled to ℃
room temperature and partitioned with Et2O and water. The aqueous phase was 
re-extracted with Et2O, and the combined organic phase was washed with brine and dried 
over MgSO4. The solvent was evaporated and prep-TLC (hexanes:EA = 3:1) gave the 
desired product 67 (24.5 mg, 0.077 mmol) in 73% yield. 
1H NMR (500 MHz, CDCl3): δ 5.41 (d, J = 9.0 Hz, 1H), 4.94 (s, 1H), 4.87 (dd, J = 10.5, 
1.5 Hz, 1H), 4.72 (s, 1H), 4.02 (t, J = 4.0 Hz, 1H), 2.78 (d, J = 17.0 Hz, 1H), 2.39 (dd, J = 
9.5, 4.5 Hz, 1H), 2.25 (d, J = 17.0 Hz, 1H), 2.06 – 1.98 (m, 1H), 1.94 (d, J = 13.0, 6.5 Hz, 
5H), 1.91 (s, 3H), 1.89 – 1.78 (m, 2H), 1.70 – 1.62 (m, 1H), 1.44 – 1.39 (m, 1H), 1.38 (s, 
3H), 1.04 – 0.96 (m, 6H), 0.91 (d, J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 
175.93, 147.98, 147.62, 122.35, 115.43, 84.37, 72.39, 58.21, 49.90, 47.66, 42.71, 41.47, 
40.84, 37.90, 28.80, 27.73, 27.24, 26.25, 23.35, 23.03; IR (NaCl, cm-1): 3487, 2957, 2924, 
2872, 1775, 1758, 1461, 1373, 1340, 1289, 1188, 1175, 992; HR-MS (FAB+) calcd for 
C20H31O3 (M+1): 319.2273, found 319.2285. 
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  To the stirred solution of 67 (60.7 mg, 0.191 mmol) in 5 mL DCM was added 0.10 mL 
TBHP (5.5 M in decane) at room temperature. And then 120 mg 4 Å molecular sieves 
was added, followed by 4.1 mg VO(acac)2. The reaction mixture was kept stirring at 
room temperature for three days. The solvent was evaporated and the residue was 
chromatographed (hexanes:EA = 3:1) to provide 14.5 mg starting material 67 and 27.7 
mg desired product 68 (yield: 43%, 57% based on recovered starting material). 
Compound 27: 1H NMR (500 MHz, CDCl3): δ 5.06 (s, 1H), 4.99 (s, 1H), 4.60 (d, J = 
10.5 Hz, 1H), 4.52 (s, 1H), 3.43 (d, J = 6.0 Hz, 1H), 2.97 (d, J = 17.0 Hz, 1H), 2.64 (s, 
1H), 2.32 (t, J = 6.0 Hz, 1H), 2.25 (d, J = 17.0 Hz, 1H), 2.04 – 1.95 (m, 2H), 1.94 – 1.81 
(m, 5H), 1.66 – 1.58 (m, 2H), 1.41 (s, 3H), 1.07 (s, 3H), 0.99 (d, J = 6.5 Hz, 3H), 0.91 (d, 
J = 6.5 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 174.98, 144.71, 115.62, 84.18, 73.09, 
67.93, 67.13, 52.92, 49.61, 45.02, 43.19, 41.45, 40.23, 38.47, 29.36, 26.96, 24.45, 22.92, 
22.85, 20.84; IR (NaCl, cm-1): 3473, 2970, 1779, 1643, 1459, 1383, 1171, 1044, 990; 
HR-MS (FAB+) calcd for C20H31O4 (M+1): 335.2222, found 335.2230. 
 
 
  To a stirred solution of 68 (14.1 mg, 0.0422 mmol) in 3 mL DCM was added 
Dess-Martin Periodinane (36 mg, 0.0844 mmol) at room temperature. 20 min later, Et2O 
was added, the solid was filtered off by a thin pad of silica gel. The filtrate was 
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evaporated and Et2O was added, the solid was re-filtered again as above. The solvent was 
evaporated and the residue was dissolved in 1 mL DCM, 0.20 mL i-Pr2NEt was added at 
room temperature. 20 min later, the volatile was evaporated and the residue was subjected 
to prep-TLC (DCM:MeOH = 40:1) to give the desired enone 69 (8.6 mg, 0.0259 mmol) 
in 61% yield from 68. 
1H NMR (500 MHz, CDCl3): δ 6.34 (s, 1H), 5.13 (s, 1H), 5.08 (s, 1H), 4.63 (t, J = 3.5 Hz, 
1H), 2.80 (d, J = 17.0 Hz, 1H), 2.67 (dd, J = 15.5, 3.0 Hz, 1H), 2.57 (dd, J = 15.5, 3.0 Hz, 
1H), 2.40 (dd, J = 19.0, 8.0 Hz, 1H), 2.25 (d, J = 17.5 Hz, 1H), 2.22 (dd, J = 19.0, 12.0 
Hz, 1H), 1.95 (s, 1H), 1.90 – 1.81 (m, 1H), 1.77 (s, 3H), 1.62 – 1.52 (m, 1H), 1.25 (s, 3H), 
1.11 (s, 3H), 1.08 (d, J = 6.5 Hz, 3H), 0.94 (d, J = 6.5 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 206.39, 175.76, 151.34, 148.38, 133.42, 113.16, 89.87, 78.16, 52.70, 48.38, 
46.03, 42.01, 41.86, 38.94, 28.58, 26.03, 23.97, 22.25, 20.44, 18.13; IR (NaCl, cm-1): 
3378, 2960, 2917, 2849, 1770, 1712, 1645, 1461, 1370, 1352, 1194, 1063, 1033; HR-MS 
(FAB+) calcd for C20H29O4 (M+1): 333.2066, found 333.2055. 
 
 
  In a vial containing 4.8 mg SeO2 was added 1 mL DCM, and then 0.10 mL anhydrous 
TBHP (5.5 M in decane) was added dropwise while stirring. 1 h later, 69 (10.6 mg, 
0.0319 mmol) in 3 mL DCM was added and the reaction mixture was stirred at room 
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temperature for 38 h, filtered through a thin pad of silica gel. The volatile was evaporated 
and prep-TLC (DCM:MeOH = 15:1) gave 1.8 mg desired product 2’ (0.0052 mmol, 16% 
yield). 
1H NMR (400 MHz, CDCl3): δ 6.41 (s, 1H), 5.36 (s, 1H), 5.00 (s, 1H), 4.65 (t, J = 3.6 Hz, 
1H), 4.40 (d, J = 10.4 Hz, 1H),  4.21 (d, J = 12.0 Hz, 1H), 2.81 (d, J = 17.6 Hz, 1H), 
2.67 (dd, J = 15.6, 3.2 Hz, 1H), 2.54 (dd, J = 15.2, 3.2 Hz, 1H), 2.41 (dd, J = 18.8, 8.0 Hz, 
1H), 2.29 – 2.15 (m, 2H), 1.90 – 1.80 (m, 1H), 1.67 – 1.59 (m, 1H), 1.34 (s, 3H), 1.11 (s, 
3H), 1.08 (d, J = 6.4 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 
206.82, 175.47, 153.53, 150.12, 135.64, 116.96, 89.12, 78.07, 67.01, 52.61, 50.27, 45.80, 
41.52, 41.22, 38.96, 28.61, 25.88, 23.96, 22.25, 18.06; IR (NaCl, cm-1): 3448, 2959, 2925, 
2855, 1772, 1750, 1725, 1638, 1458, 1350, 1286, 1190, 1060, 1019; HR-MS (ES+) calcd 









































































































































Comparison of 1H NMR spectra of natural and synthetic tricholomalide B (2) with the 













Comparison of 1H NMR spectra of natural and synthetic tricholomalide A (1). δfrom 8.0 




























































































































2.1 Angiogenesis and Anti-Angiogenic Agents 
Angiogenesis is the process of new blood vessel formation in tissues, and it is an 
essential biological process for embryonic development, reproduction, and wound 
healing.1 Angiogenesis is modulated by a series of stimulators and inhibitors, such as 
vascular endothelial growth factor (VEGF) and angiopoietin 1 (ANGPT1), so 
angiogenesis is usually focal and self-limited in time in regular tissues. 2  However, 
angiogenesis imbalance is related to a variety of diseases, such as atherosclerotic plaques, 
diabetic retinopathy, and tumors. For example, tumors secrete excess of angiogenic 
factors, and induce uncontrolled angiogenesis towards tumors for their survival, 
development and metastases. Thus, restricting tumor angiogenesis has been a therapeutic 
principle in cancer research.3 Also, controlling angiogenesis has been considered as a 
treatment not only for cancer, but also for other angiogenesis-dependent diseases. 
    Besides cancer, another angiogenesis-related disease is the ‘wet’ age-related macular 
degeneration.4 This disease destroys patients’ central vision, thus causing the patients 
difficulties in performing daily tasks. Abnormal angiogenesis in choriocapillaris accounts 
for the condition. The new blood vessels tend to leak blood and fluids, and destroy 
patients’ sight. Thus, Anti-angiogenesis treatment options are promising methods for 
treating ‘wet’ age-related macular degeneration.5 In fact, angiogenesis has become an 
                                                            
1 Figg, W. D.; Folkman, J. Angiogenesis – An Integrative Approach from Science to Medicine (Springer Science + 
Business Media, LLC) 2008, v – vi, 1 – 14. 
2 Folkman, J. Nat. Rev. Drug Discovery 2007, 6, 273–286. 
3 Folkman, J.; Klagsbrun, M. Science 1987, 235, 442 – 447. 
4 http://www.nei.nih.gov/health/maculardegen/armd_facts.asp 
5 Kulkarni, A. D.; Kuppermann, B. D. Adv. Drug Delivery Rev. 2005, 57, 1994– 2009. 
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‘organizing principle’ that promotes building up correlations of different diseases and 
broadening the therapeutic spectrum of different drugs.2  
Several angiogenesis inhibitors have been approved as drugs by U. S. Food and Drug 
Administration, and they are categorized into three classes based on their mechanism of 
action.2 The first class of drugs blocks one main angiogenic protein. Avastin, which 
blocks VEGF, is a member of the first class. The second class blocks two or three main 
angiogenic proteins. An example of this second class is Sutent, which downregulates the 
VEGF receptor 2, PDGF (platelet-derived growth factor) receptor, and cKIT receptor. 
The third class, which includes the drug Caplostatin, deals with a broad range of 
angiogenic regulators. Although our arsenal of angiogenesis inhibitors increases, drug 
resistance becomes a serious problem. Tumors have different ways to induce 
angiogenesis and blocking one pathway forces tumors to use other pathways, which 
causes drug resistance.6 Thus, the continual development of angiogenesis inhibitors and 
discovery of new anti-angiogenic mechanisms widens the therapeutic spectrum by 
making available a cocktail of orthogonal drugs. 
 
2.2 Background of Cortistatins and Synthetic Studies by Other Groups 
In searching anti-angiogenetic substances, the Kobayashi group discovered a family of 
steroidal alkaloids, cortistatins A – H and J – L (Scheme 1), from the marine sponge 
                                                            
6 Carmeliet, P.; Jain, R. K. Nature 2000, 407, 249 – 257. 
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Corticium simplex via bioassay-guided seperation. 7  Particularly, cortistatin A 
demonstrated strong growth-inhibitory activity against human umbilical vein endothelial 
cells (HUVECs) with IC50 of 1.8 nM and selective indexes of above 3000 to normal 
human dermal fibroblast (NHDF) and other tumor cell lines, such as KB epidermoid 
carcinoma cells (KB3-1), murine neuroblastoma cells (Neuro2A), human chronic 
myelogenous leukemia cells (K562). In addition, the Nicolaou group later found high 
selective indexes of cortistatin A to other human cell lines, including MCF-7 (Michigan 
Cancer Foundation – 7, breast cancer), NCI H460 (lung cancer), SF268 (central nervous 
system cancer), IA9 (ovarian cancer) and its drug-resistant mutants PTX10 (taxol-
resistant) and A8 (epothilone-resistant).8  Cortistatin A also showed inhibitory effects 
against the migration of HUVECs and tubular formation induced by VEGF and bFGF at 
a concentration of 2 nM, which showed comprehensive activity against 
neovascularization.9 Thus, the isolated cortistatin family of natural products, especially 
cortistatin A and J, have strong anti-angiogenesis activity and might serve as potent 





7 (a) Aoki, S.; Watanabe, Y.; Sanagawa, M.; Setiawan, A.; Kotoku, N.; Kobayashi, M. J. Am. Chem. Soc. 2006, 128, 
3148 – 3149. (b) Watanabe, Y.; Aoki, S.; Tanabe, D.; Setiawan, A.; Kobayashi, M. Tetrahedron 2007, 63, 4074 – 
4079. (c) Aoki, S.; Watanabe, Y.; Tanabe, D.; Setiawan, A.; Arai, M.; Kobayashi, M. Tetrahedron Lett. 2007, 48, 
4485 – 4488. Unless otherwise stated, all numberings are based on the numbering system of cortistatin A. 
8 Nicolaou, K. C.; Peng, X.-S.; Sun, Y.-P.; Polet, D.; Zou, B.; Lim, C. S.; Chen, D. Y.-K. J. Am. Chem. Soc. 2009, 131, 
10587 – 10597. 
9 Aoki, S.; Watanabe, Y.; Tanabe, D.; Arai, M.; Suna, H.; Miyamoto, K.; Tsujibo, H.; Tsujikawa, K.; Yamamoto, H.; 
Kobayashi, M. Bioorg. Med. Chem. 2007, 15, 6758–6762. 
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Scheme 1. Cortistatin Family Natural Products and Their IC50 against HUVECs. 
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    All cortistatins share a unique 9(10-19)-abeo-androstane-type steroidal core including 
an oxabicyclo[3.2.1]octene motif, with three different kinds of side chains on C17 (either 
isoquinoline, 3-methylpyridine, or methylpiperidine) as well as different oxidation levels 
in the A ring. After the initial structure-activity relationship (SAR) study by Kobayashi 
group,9 Cee, Chen, Lee and Nicolaou reported their binding assay screening which 
indicated strong binding affinity of cortistatin A towards a series of biologically essential 
kinases with extended C-termini, such as cyclin-dependent kinases CDK8, CDK11, and 
Rho-associated coiled-coil containing protein kinases ROCK I and ROCK II.10 Docking 
simulations suggested that cortistatin A is in close proximity with the aromatic side chain 
of the extended C-terminal domain of those kinases and thus blocks ATP-binding sites. 
The isoquinoline moiety of cortistatin A points inside the kinase hinge, the steroid 
skeleton blocks the ATP-binding mouth, and the A ring hydroxyls point to the solvent. 
Thus, the cytostatic activity to HUVECs of cortistatins was proposed due to their 
inhibition of some kinases in HUVECs, consequently preventing HUVECs proliferation 
and migration. 
    Not surprisingly, the potent biological activity and unique structures of cortistatins 
have attracted many groups to explore their synthesis. To date five total syntheses have 
been achieved by Baran, Nicolaou, Shair, Myers and Hirama groups, with two formal 
syntheses by Sarpong and Yang groups. Many synthetic studies towards the steroidal 
cortistatin core have been published. Here I will summarize the synthetic endeavors from 
other groups. 
                                                            
10 Cee, V. J.; Chen, D. Y.-K.; Lee, M. R.; Nicolaou, K. C. Angew. Chem. Int. Ed. 2009, 48, 8952 – 8957. 
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    In 2008, Baran group reported the first synthesis of cortistatin A from steroid 
prednisone (Scheme 2).11 The strategy took advantage of the steroidal skeleton, and 
employed an elegant A ring functionalization, then B ring expansion (C19 incooperated 
into B ring) and functionalization, and isoquinoline appendage. The hetero-adamantane 
formation and subsequent C-H activation demonstrate their creativity and bravery. The 
carefully-planned and well-integrated transformations made possible large scale synthesis 
of cortistatin A. They also found the stereochemistry on C17 played a pivotal role in the 
anti-angiogenic activity of cortistatin A.12 
Scheme 2. Baran’s Synthesis of Cortistatin A 
 
                                                            
11 (a) Shenvi, R. A.; Guerrero, C. A.; Shi, J.; Li, C.-C.; Baran, P. S. J. Am. Chem. Soc. 2008, 130, 7241 – 7243. (b) Shi, 
J.; Manolikakes, G.; Yeh, C.-H.; Guerrero, C. A.; Shenvi, R. A.; Shigehisa, H.; Baran, P. S. J. Am. Chem. 
Soc. 2011, 133, 8014 - 8027. 
12 Shi, J.; Shigehisa, H.; Guerrero, C. A.; Shenvi, R. A.; Li, C.-C.; Baran, P. S. Angew. Chem. Int. Ed. 2009, 48, 4328 – 
4331. 
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    Later in 2008, the Nicolaou-Chen group at Singapore reported the second synthesis of 
cortistatin A (Scheme 3).13 Their synthesis was based on a convergent strategy to set up 
the pentacyclic core through a cascade Michael addition-aldol condensation reaction. 
They also perceived the all anti- relationship of the A ring functionality and set up those 
functional groups through epoxide opening. 
Scheme 3. Nicolaou-Chen’s Total Synthesis of Cortistatin A 
 
    In late 2008, the Shair group published its short synthesis of cortistatin A.14 They 
started from Hajos-Parrish ketone (22) and set up the B ring through ring expansion. A 
brave and creative aza-Prins/transannular cyclization furnished 25 directly in high yield. 
The whole sequence well exemplified the classical but permanent concept of ‘ideal 
synthesis’ in the field of total synthesis of natural products.15 
 
                                                            
13 (a) Nicolaou, K. C.; Sun, Y.-P.; Peng, X.-S.; Polet, D.; Chen, D. Y.-K. Angew. Chem. Int. Ed. 2008, 47, 7310 – 7313. 
(b) Nicolaou, K. C.; Peng, X.-S.; Sun, Y.-P.; Polet, D.; Zou, B.; Lim C. S.; Chen, D. Y.-K. J. Am. Chem. Soc. 2009, 
131, 10587 – 10597. 
14 Lee, H. M.; Nieto-Oberhuber, C.; Shair, M. D. J. Am. Chem. Soc. 2008, 130, 16864 – 16866. 
15 Gaich, T.; Baran, P. S. J. Org. Chem. 2010, 75, 4657 – 4673. 
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Scheme 4. Shair’s Total Synthesis of Cortistatin A 
 
    The Myers group published its synthesis of cortistatins A, J, K and L in 2010 (Scheme 
5). 16  They envisioned the four cortistatins would be synthesized from a shared 
intermediate. They employed a convergent route to set up the pentacyclic core and 
utilized additional transformations for the A ring functionalization. The radical 
deoxygenation on C17 was also achieved using a modified condition. 
Scheme 5. Myers’ Total Synthesis of Cortistatins A, J, K and L 
 
                                                            




    The Hirama group employed a novel Knoevenagal reaction followed by a 6π 
electrocyclization and an intramolecular radical cyclization reaction to build up the 
pentacyclic core of cortistatin A. They also achieved the Grignard-type addition followed 
by Barton-McCombie deoxygenation (together with dechlorination) to stereoselectively 
install the isoquinoline moiety. Several steps reported in Nicolaou’s synthesis were also 
optimized, and Hirama group obtained both cortistatins A and J (Scheme 6).17 
                                                            
17 (a) Yamashita, S.; Iso, K.; Hirama, M. Org. Lett. 2008, 10, 3413 – 3415. (b) Yamashita, S.; Kitajima, K.; Iso, K.; 
Hirama, M. Tetrahedron Lett. 2009, 50, 3277 – 3279. (c) Yamashita, S.; Iso, K.; Kitajima, K.; Himuro, M.; Hirama, 
M. J. Org. Chem. 2011, 76, 2408 – 2425. 
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Scheme 6. Hirama’s Synthesis of Cortistatins A and J 
 
    The Sarpong group employed a novel Pt-catalyzed cycloisomerization reaction to build 
up the B ring, and an oxidative dearomatization provided the pentacyclic core 41 of 
cortistatin A. They transferred 41 into Hirama-Nicolaou’s intermediate 20 to complete 
the formal synthesis (Scheme 7).18 
Scheme 7. Sarpong’s Formal Synthesis of Cortistatin A 
 
                                                            
18 (a) Simmons, E. M.; Hardin, A. R.; Guo, X.; Sarpong, R. Angew. Chem. Int. Ed. 2008, 47, 6650 – 6653. (b) Simmons, 
E. M.; Hardin-Narayan, A. R.; Guo, X. L.; Sarpong, R. Tetrahedron 2010, 66, 4696 – 4700. 
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    The Yang group advanced an intramolecular furan Diels-Alder reaction to quickly set 
up the A-B ring system, and after oxidative dearomatization and ether formation, they 
finally obtained 45 which had been used in Myers’ synthesis of cortistatins A, J, K and L 
(Scheme 8).19 
Scheme 8. Yang’s Formal Synthesis of Cortistatins 
 
   In addition to the total and formal syntheses of cortistatins, a series of synthetic studies 
have been reported (Scheme 9), each of which provided beautiful insights to solving the 
synthetic challenges of cortistatins, especially the B ring formation, such as a relay 
enyne-ene metathesis (Stoltz), 20  cyclopropene Diels-Alder (Magnus), 21  [4+3] 
cycloaddition with furan (Gung, Zhai, Chiu),22 1,3-dipolar cycloaddition with nitrile-
                                                            
19 (a) Liu, L.; Gao, Y.; Che, C.; Wu, N.; Wang, D. Z.; Li, C. C.; Yang, Z. Chem. Commun. 2009, 662 – 664. (b) Fang, 
L.; Chen, Y.; Huang, J.; Liu, L.; Quan, J.; Li, C.-C.; Yang, Z. J. Org. Chem. 2011, 76, 2479 – 2487. 
20 Baumgartner, C.; Ma, S.; Liu, Q.; Stoltz, B. M. Org. Biomol. Chem. 2010, 8, 2915 – 2917. 
21 Magnus, P.; Littich, R. Org. Lett. 2009, 11, 3938 – 3941. 
22 (a) Craft, D. T.; Gung, B. W. Tetrahedron Lett. 2008, 49, 5931 – 5934. (b) Yu, F.; Li, G.; Gao, P.; Gong, H.; Liu, Y.; 
Wu, Y.; Cheng, B.; Zhai, H. Org. Lett. 2010, 12, 5135 – 5137. (c) Liu, L. L.; Chiu, P. Chem. Commun. 2011, 47, 
3416 – 3417. The Funk group recently published their elegant total synthesis of cortistatin J using a [4+3] method, 
see: Nilson, M. G.; Funk, R. L. J. Am. Chem. Soc. 2011, ASAP, DOI: 10.1021/ja206138d. 
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oxide (Sorensen), 23  intramolecular Heck reaction (Kobayashi), 24  and Demjanov ring 
expansion (Corey). 25 These synthetic studies provided different routes which might lead 
to different analogs for biological evaluation. 




23 Frie, J. L.; Jeffrey, C. S.; Sorensen, E. J. Org. Lett. 2009, 11, 5394 – 5397. 
24 Kotoku, N.; Sumii, Y.; Kobayashi, M. Org. Lett. 2011, 13, 3514 – 3517. 
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    Besides those synthetic efforts towards the natural cortistatins, the synthetic 
community also made a variety of cortistatin analogs for further biological studies. Listed 
below are representatives (Scheme 10).12,13b,26 








    Based on the existing data of cortistatin family of natural products and their analogs, 
scientists have discovered some important functionality required to maintain their 
biological activity.26 Other structural features might also be essential for the inhibitory 
activity towards HUVECs, such as the A-B-C ‘skeleton angle’, the flatness of the A-B-C 
rings (Scheme 11). All this information might help develop further cortistatin analogs. 
Scheme 11. Essential Functionalities for Cortistatins’ Biological Activity 
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Some cortistatin analogs are proposed here based on the analysis above. It is hoped 
that these analogs will open new research avenues on angiogenesis and anti-angiogenic 
treatments (Scheme 12). 




2.3 Our Synthetic Plan 
    All cortistatins share a rearranged steroid skeleton, thus, based on plenty of synthetic 
studies of steroids, one may consider invoking the wisdom of existing strategies when 
devising a synthetic route.27 The B ring strategy and C ring strategy for steroid synthesis, 
such as o-quinodimethide Diels-Alder28 and Torgov’s method,29 respectively, have been 
widely used because they are convergent. For cortistatin A, disconnection on the B ring 
would lead to two pieces. The A ring piece could arrive from benzene framework, and 
the C-D ring system shared a pattern of Hajos-Parrish ketone, 30,31 which could be made 
in high optical purity. Formation of the B ring followed by oxidative dearomatization 
would set up the oxa-bridge. After A ring functionalization facilitated by the existing 
ketone on C2, the isoquinoline moiety would be appended in the end (Scheme 13). 
Scheme 13. Synthetic Plan to Cortistatin A 
 
                                                            
27 Chapelon, A.-S.; Moraléda, D.; Rodriguez, R.; Ollivier, C.; Santelli, M. Tetrahedron, 2007, 63, 11511 – 11616. 
28 Kametani, T.; Nemoto, H. Tetrahedron, 1981, 37, 3 – 16. 
29 Ananchenko, S. N.; Torgov, I. V. Tetrahedron Lett. 1963, 4, 1553 – 1558. 
30 Hajos, Z. G.; Parrish, D. R. Org. Syn., Coll. Vol. 1990, 7, 363 – 368. 
31 Wilson, R. M.; Danishefsky, S. J. J. Org. Chem. 2007, 72, 4293 – 4305. 
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2.4 Early Synthetic Studies 
    The cortistatin project was initiated by a former graduate student Dr. Mingji Dai in 
early 2007, and I was involved in the model studies of the nitrone-aryne [3+2] reaction in 
2008. After Mingji’s graduation, Dr. Peter Park and I took over the project to work on the 
A-ring functionalization of cortistatin A. Here I will briefly summarize the endeavors 
before Mingji’s graduation. A detailed description is available in his dissertation 
(Columbia University, 2009). 
2.4.1 The oxidative dearomatization approach 
    The oxidative dearomatization model was tested first. When 68 was treated with PIDA, 
desired ether formation occurred after oxidative dearomatization. However, when 70 was 
subjected to the same condition, acetonitrile was involved in the reaction and 72 was 
obtained as the final outcome. This result indicated that the double bond in the seven-
membered ring played an important role, and we believed that constraints imposed by the 
double bond might account for the observed result (Scheme 14).32 














70 71 72  
                                                            
32 Dai, M.; Danishefsky, S. J. Heterocycles, 2009, 77, 157 – 161. 
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Encouraged by the successful model studies of oxidative dearomatization, the real 
system was tried. Deconjugative alkylation was attempted between 73 and 74, and only 
30% of desired 75 was obtained. The major problem encountered in this route was the 
conjugative reduction followed by trapping the enolate with TMSCl (for Rubottom 
oxidation). Although simple cases have been reported for this kind of reduction, complex 
substrates, especially tetrasubstituted olefin, were not suitable reactants (Scheme 15).33 
Scheme 15. Attempts to Make trans-Fused C-D Ring System 
 
To solve this problem, an Ireland-Claisen approach was conducted. It took advantage 
of the previously reported alcohol 77,34 and after Claisen rearrangement,35 the Δ8,9-double 
bond was able to be used for further transformation, such as oxidations to 80. The well-
planned sequence quickly set the stage for the C9-C19 bond formation although, after 
various attempts, methylenation of C9 ketone failed due to severe 1,3-diaxial interaction. 
Only a small base methyllithium would deprotonate on C11, and after the enolate reacted 
                                                            
33 (a) Groth, U.; Kohler, T.; Taapken, T. Tetrahedron, 1991, 47, 7583 – 7592. (b) Groth, U.; Taapken, T. Liebigs Ann. 
Chem. 1994, 669 – 671. 
34 Isaacs, R. C. A.; Di Grandi, M. J.; Danishefsky, S. J. J. Org. Chem. 1993, 58, 3938 – 3941. 
35 (a) Ziegler, F. E. Chem. Rev. 1988, 88, 1423 – 1452. (b) Castro, A. M. M. Chem. Rev. 2004, 104, 2939 – 3002. 
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with PhNTf2, triflate 81 was obtained. An intramolecular Heck reaction successfully 
formed the B ring, following the same protocol as the taxol synthesis reported by our 
group before.36 However, this route was finally abandoned because cleavage of the exo-
cyclic carbon on B ring was never achieved and intermediate 83 or similar structures 
could not be obtained (Scheme 16). 
Scheme 16. Ireland-Claisen Rearrangement and Intramolecular Heck Reaction 
 
                                                            
36 (a) Young, W. B.; Masters, J. J. Danishefsky, S. J. J. Am. Chem. Soc. 1995, 117, 5228 – 5234. (b) Masters, J. J.; Link, 
J. T.; Snyder, L. B.; Young, W. B.; Danishefsky, S. J. Angew. Chem. Int. Ed. 1995, 34, 1723 – 1726. (c) Danishefsky, 
S. J.; Masters, J. J.; Young, W. B.; Link, J. T.; Snyder, L. B.; Magee, T. V.; Jung, D. K.; Isaacs, R. C. A.; Bornmann, 
W. G.; Alaimo, C. A.; Coburn, C. A.; Di Grandi, M. J. J. Am. Chem. Soc. 1996, 118, 2843 – 2859. 
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2.4.2 The Snieckus coupling and alkylative dearomatization approach 
    With difficulties to build the B ring successfully, other strategies were conceived and 
compared. After careful consideration, a strategy based on the benzodihydropyran moiety 
was chosen. The benzodihydropyran could be made from 6π-electrocyclization reaction 
of an o-quinonemethide, and the C6-C7 carbon chain could be made by alkylative 
dearomatization (Ar1-participation).37 The o-quinomethide could be easily generated by 
o-hydroxybenzylamine derivatives, 38  and linking the N-O atoms would implicate an 
aryne-nitrone [3+2] cycloaddition product (Scheme 17). 
Scheme 17. Second Generation Retrosynthetic Proposal 
 
                                                            
37 (a) Winstein, S.; Baird, R. J. Am. Chem. Soc. 1957, 79, 756 – 757. (b) Masamune, S. J. Am. Chem. Soc. 1961, 83, 
1009 – 1010. (c) Lalic, G.; Corey, E. J. Org. Lett. 2007, 9, 4921 – 4923. 
38 Tang, Y.; Oppenheimer, J.; Song, Z.; You, L.; Zhang, X.; Hsung, R. P. Tetrahedron 2006, 62, 10785 – 10813. 
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    Model systems were tried. The first set of examples demonstrated that good 
regioselectivity of the nitrone-aryne [3+2] cycloaddition was realized by the ortho-
substituents of the aryne, but a meta/para- substituent gave poor regioselectivity. Thus, 
an inductive effect played the dictating role of the regioselectivity here. The same trend 
of regioselectivity was reported before (Scheme 18).39 
Scheme 18. Regioselectivity of Nitrone-Aryne [3+2] Cycloaddition 
 
    The model for alkylative dearomatization was later pursued. In order to secure the 
regioselectivity, an inductively electron-withdrawing group, such as MeO-, was 
introduced, and the methoxy group could later serve as C1 hydroxyl of cortistatin A. The 
                                                            
39 Matsumoto, T.; Sohma, T.; Hatazaki, S.; Suzuki, K. Synlett 1993, 843 – 846. 
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N-O cleavage was achieved under mild conditions, and the o-quinomethide was easily 
generated, which underwent 6π-electrocyclization in high yield. The alkylative 
dearomatization proceeded without difficulties, and the cortistatins’ core could be made 
efficiently (Scheme 19). 
Scheme 19. Model Studies of Cortistatins’ A-B-C Ring Framework 
 
    Another method to generate o-quinomethide is the Snieckus-type reaction. Slightly 
different from the original reports by Snieckus,40 the Alvarez-Manzaneda group reported 
a facile method where the 1,4-elimination would proceed with phenoxide 105, where a o-
quinomethide 106 could be isolated.41  This simplified method would help provide a 
domino reaction of coupling/carbamoyl migration/elimination/electrocyclization, and the 
desired intermediate 110 would be made in one pot (Scheme 20). 
                                                            
40 (a) Chauder, B. A.; Kalinin, A. V.; Taylor, N. J.; Snieckus, V. Angew. Chem. Int. Ed. 1999, 38, 1435 – 1438. (b) 
Chauder, B. A.; Kalinin, A. V.; Snieckus, V. Synthesis 2001, 140 – 144. 
41 Alvarez-Manzaneda, E. J.; Chahboun, R.; Pérez, I. B.; Cabrera, E.; Alvarez, E.; Alvarez-Manzaneda, R. Org. Lett. 
2005, 7, 1477 – 1480. 
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Scheme 20. Snieckus-Type Domino Reaction 
 
This Snieckus-type reaction worked well in our practice, although the products formed 
at first were the wrong epimers at C8, which was probably due to the 1,3-diaxial 
interaction of C18 and C6-C7 chain. Since the electrocyclization was reversible via o-
quinomethide intermediate, heating at a higher temperature happily provided the desired 
epimers at C8 as the major products. The different epimerization temperatures of 
different substrates might suggest the o-quinomethide intermediates have different 
stabilities. The 1,3-diaxial interaction could also be tuned by distance, which was 
adjusted by Δ11,12- or Δ14,15-double bonds (Scheme 21). 
 
185 
Scheme 21. Snieckus-Type Domino Reaction 
 
    Alkylative dearomatization proceeded well according to Corey’s procedure.37c Since 
the Δ14,15-double bond could not be selectively hydrogenated after the C8 epimerization 
step, 119 was chosen for A ring functionalization (Scheme 22). 
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Scheme 22. Alkylative Dearomatization 
 
    Mingji also tried various methods to install the C3 dimethylamino group.42 The basic 
idea was using electrophilic amination. After various attempts, no desired product with an 
amino group was obtained although nitrogen could be introduced at C3 (Scheme 23). 
Scheme 23. Attempts to Introduce Dimethylamino Group 
 
2.5 Attempts to Finish a Formal Synthesis 
When Dr. Park and I took over this project, we first set out to achieve a formal 
synthesis: the Hirama and Nicolaou’s intermediate 20 would be a good target. In our 
                                                            
42 Ricci, A. Modern Amination Methods (Wiley-VCH: Weinheim) 2000. 
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effort to remove oxygen on C2, converting 119 to triflate 126 was not a reproducible 
process. Tosylhydrazone 129 didn’t undergo Shapiro reaction,43 and Barton-McCombie 
deoxygenation reaction did not work either (Scheme 24).44 
Scheme 24. Attempts to Deoxygenation on C2 
 
    An interesting reaction was observed when 130 was subjected to acidic hydrolysis. 
Intermediate 132 was the product obtained rather than the desired 133. We believed that 
the methyl enol ether with a large conjugated system in 130 was difficult to hydrolyze, 
while the methyl enol ether in 136 was easier to hydrolyze because C12 in 130 had less 
                                                            
43 (a) Shapiro, R. H.; Heath, M. J. J. Am. Chem. Soc. 1967, 89, 5734 – 5735. (b) Shapiro, R. H.; Duncan, J. H. Org. Syn., 
Coll. Vol. 1988, 6, 172 – 175. 
44 (a) Barton, D. H. R.; McCombie, S. W. J. Chem. Soc., Perkin Trans. 1 1975, 1574 – 1585. (b) Hartwig, W. 
Tetrahedron, 1983, 39, 2609 – 2645. 
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negative charge than C2 in 136. The C2 hydroxyl group was very labile, which was a 
major problem we encountered later on (Scheme 25). 
Scheme 25. An Interesting Hydrolysis and Proposed Mechanism 
 
 
2.6 Introduction of C3 Amino Group 
We then decided to achieve the A ring functionalization of cortistatin A, aiming a total 
synthesis. The two hydroxyl groups at C1 and C2 and the dimethylamino group at C3 all 
process equatorial positions, thus we believe they can be installed stereoselectively using 
small borohydride reduction of the corresponding iminium and ketones.45 The strategy 
was designed to introduce nitrogen on C3 first by taking advantage of the ketone on C2 
and then reduce ketones on C2 and C1 (after deprotection). 
                                                            
45 Seyden-Penne, J. Reductions by the Alumino- and Borohydrides in Organic Synthesis 2nd ed. (Wiley-VCH, Inc.) 
1997. 
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Introduction of nitrogen on C3 turned out to be quite difficult. Besides Mingji’s 
attempt of direct electrophilic enolate amination, various other routes have been tried, 
such as Neber reaction,46  silyl enol ether aziridination,47  all of which failed to give 
desired products. Dimethylamine displacement of 139 gave predominantly the 
elimination product 119 despite the fact that the reaction worked well in a model system 
143. The difference could be due to different strains of the two systems (Scheme 26).  
Scheme 26. Dimethylamine Displacement Attempt 
 
                                                            
46 (a) O’Brien, C. Chem. Rev. 1964, 64, 81 – 89. 
47 (a) Evans, D. A.; Faul, M. M.; Bilodeau, M. T. J. Org. Chem. 1991, 56, 6744 – 6746. 
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Finally, azide displacement of 139 gave 146 probably through 145 which underwent 
elimination spontaneously. A similar case was reported in literature.48 Furthermore, 147 
was subject to enamine reduction conditions and gave α-amino-trienone 148 with correct 
stereochemistry. It was found that 148 was a little sensitive to air, so it was quickly 
reduced and amino alcohol 149 was furnished (Scheme 27). 


















































48 Shawakfeh, K. Q.; Al-Said, N. H.; Al-Zoubi, R. M. Steroids 2008, 73, 579 – 584. 
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Deprotection of methoxy on C1 was not achieved under the conditions we tried. Only 
nucleophilic deprotection methods using NaSEt and NaI were tried because of shortage 
of materials, and we changed the methyl protecting group on the C1 enol to 
methoxymethyl protecting group, hoping MOM would be easier to deprotect (Scheme 
28). 
Scheme 28. Attempts to Deprotect Methyl Enol Ether on C1 
 
 
2.7 Deprotection of MOM Enol Ether on C1 
2.7.1 Intermediate preparation 
To change the protecting group from Me to MOM on the C1 enol, the synthetic 
sequence developed by Mingji was followed and optimized. The aromatic A ring 
precursor 159 was synthesized in six steps from commercially available 2,5-
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dihydroxybenzaldehyde 153. Thus, 153 was brominated and selectively acylated to 
generate carbamate 154 in 48% yield for 2 steps. The TBS protection product 155 was 
subjected to Baeyer-Villiger oxidation followed by saponification and subsequent MOM 
protection to give 159 in 56% yield from 154. The Snieckus coupling reaction worked 
well with a yield of 51% to 60%, furnishing tetracyclic compound 160. In large scales, 
the reaction time could be substantially shortened to 20 min, probably because of 
increased concentration. Usually, the reaction was complete when a large quantity of 
solid precipitated. Epimerization of 160 at C8 was achieved when 160 was heated in THF 
at 192 ℃ oil bath in a sealed tube overnight, providing 162 and 161 in a 2.5:1 ratio 
favoring the desired isomer 162 after selective deprotection of primary TBS ether.49 And 
161 was recycled by introducing TBS group to regenerate 160. Intermediates 161 and 
162 were assigned based on Mingji’s NMR and X-ray data. Tosylation of alcohol 162 
followed by alkylative dearomatization using TBAF gave desired pentacyclic 164 in 95% 
and 94% yield, respectively (Scheme 29). 
    The pentacyclic core 164 was further advanced to introduce amino group on C3 in a 
similar manner to what has been described above. Thus, conjugative reduction with L-
Selectride followed by bromination using 5,5-dibromo-Meldrum’s acid (138) furnished 
165 in about 1.25:1 ratio of epimers. Both epimers could react with n-Bu4NN3 to give 
166 in THF, and the crude 166 (after evaporation of THF) could be reduced using 
NaBH3(CN) in dichloromethane. It was found that solvent selection was crucial for the 
reaction rate and desired stereoselectivity in the reactions from 165 to 167. Again, 167 
was quickly reduced under Luche conditions (washing by NH3·H2O was to break amine-
                                                            
49 Smith, III, A. B.; Sperry, J. B.; Han, Q. J. Org. Chem. 2007, 72, 6891 – 6900. 
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borane complex of 168).50 Intermediate 168 could be protected as carbamates (Scheme 
30). 
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50 Luche, J. L. J. Am. Chem. Soc. 1978, 100, 2226 – 2227. 
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Scheme 30. Functionalization of C2 and C3 
 
2.7.2 Bromine-induced deprotection of MOM and some interesting findings 
Hoping the MOM enol ether would be more easily deprotected than methyl enol ether, 
a model system 171 (made in the same way as 130 from 164) and its derivative 172 was 
tried first. However, in various attempts, the deprotection failed to give the desired 
dienone, and sometimes a ‘solvolysis’ reaction was observed.  Similar to the case in 
Scheme 25, a bromide here serves as a stronger and charged nucleophile. We believed 
that acid-catalyzed deprotection of the C1 MOM was not promising. Among the three 
indicated oxygens in 175, oxygen b might not be nucleophilic enough to coordinate with 
the Lewis acid (to form 176) or to push away a leaving group (to form 177) because of 
195 
conjugation to the triene. Thus starting material was recovered or oxygen c reacted first 
to give side products (Scheme 31). 
Scheme 31. Attempts to Deprotect MOM on C1 Enol 
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When we were thinking of alternative ways for MOM deprotection, the triene system 
attracted our attention. It would be possible that electrophiles attack the triene so that C1 
becomes very electrophilic towards hydrolysis or the MOM group could be driven to 
collapse itself. Happily, the bromine-induced MOM deprotection of MOM enol ether 
work well under mild conditions although Hg(II) did not.51 Interestingly, some ω-bromo 
dienones were not very stable and an elimination of HBr occurred on silica gel or even 
when an EtOAc solution of them was concentrated under reduced pressure, so only Et2O 
solution should be used for workup without chromatography (Scheme 32). 
Scheme 32. Bromine-Induced Deprotection 
 
                                                            
51 For similar reactions, see: (a) Ciufolini, M. A.; Deaton, M. V.; Zhu, S. Chen, M. Tetrahedron, 1997, 53, 16299 – 




    The unexpected formation of 182 might actually open a new avenue. A tandem 
reaction of C2 ketone reduction, trienol-dienone tautomerization and followed by C1 
ketone reduction would give trans- diol on C1 and C2 directly. Protic solvents such as 
alcohols would serve as reasonable media to facilitate proton transfer, and Luche 
reduction would provide the 1,2-reduction selectively.50 In fact, Luche reduction of 182 
or its TBS ether surprisingly give 183, which had an extra hydroxyl on C12, not 185 
(Scheme 33). This looked mysterious to us at first, but finally we found a plausible 
explanation although further experiments were needed to confirm it (vide infra). 








































    It seemed that radical methods could be used for debromination reactions, and 
Hirama’s precedent results convinced us that the radical debromination reaction should 
be a high-yielding reaction.17a,c However, model studies showed that an isomer 188 was 
the major product. Interestingly, when the reaction mixture was subjected to prep-TLC 
under air, some of 188 converted to 189 (Scheme 34). The structure of 189 was 
supported by 1H NMR and LR-MS. 
Scheme 34. Model Studies of Radical Debromination 
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    The unexpected facile formation of 189 was quite surprising. Perhaps 18O2 experiments 
would provide further confirmation in our experiments. Considering the ease with which 
188 tautomerized into its trienol form 193 under acidic conditions (silica gel), it would be 
possible that 193 was actually the reactive intermediate leading to 189. It is known from 
the literature that similar systems react with O2, such as in synthetic studies towards G 
factors 52  and some steroids. 53  Electron paramagnetic resonance (EPR)/spin trapping 
studies supported a stepwise radical pathway involving triplet oxygen (Scheme 35).54 
Degassing the system by freeze-pump-thaw did not help to prevent the peroxidation in 
our attempt on a small scale. 
Scheme 35. Dienol/Trienol Peroxidation with Triplet Oxygen 
 
                                                            
52 Gavrilan, M.; André-Barrès, C.; Baltas, M.; Tzedakis, T.; Gorrichon, L. Tetrahedron Lett. 2001, 42, 2465 – 2468. 
53 Liu, L.-G.; Su, X.-D.; Li, Z.-S. Syn. Comm. 1995, 25, 3113 – 3124. 




    The analysis above would be suitable to explain Scheme 33. Thus, 182 underwent 
Luche reduction on C2 ketone, generating 200, and peroxidation occurred at a faster rate 
than enol-ketone tautomerization, furnishing 201. Intermediate 201 was thoroughly 
reduced to give 183 (Scheme 36). It should be noted that 200 might exist in its enolate 
form during the reaction and the peroxidation step was very fast.55 Enolate peroxidation 
by O2 had also been suggested through a radical pathway (chain reaction).56 



































55 Wasserman, H. H.; Lipshutz, B. H. Tetrahedron Lett. 1975, 16, 1731 – 1734. 
56 Gersmann, H. R.; Bickel, A. F. J. Chem. Soc., (B) 1971, 2230 – 2237. 
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Coming back to the synthetic route, we found the radical debromination reaction did 
not work well with intermediate 203. It was a messy reaction with a great deal of 
decomposition, although the desired product could be isolated in about 10% yield. The 
reaction should be monitored by 1H NMR in a C6D6 solution, and the presence of a small 
peak (dd, δ = 5.41 ppm, J = 5.1, 2.6 Hz) indicated the formation of the desired product 
204. Thorough degassing by freeze-pump-thaw (at least 4 cycles) was required. The 
compounds with Fmoc protection of C3 amine finally looked really promising while the 
Boc series met some deprotection problems. The final steps still need optimization and/or 
confirmation because we met some stability and purification problems (Scheme 37). 





    In conclusion, A ring functionalization of pentacyclic core 164 was advanced towards 
the synthesis of cortistatin A. The C3 amino group was introduced by an azide 
displacement and enamine reduction, and the stereoselective hydroxyl formation was 
achieved by Luche reduction. Deprotection of C1 enol ether was very challenging, and in 
the end bromine-induced deprotection gave some promising results albeit in low yield. 
During the deprotection attempts of C1 enol ether, some preliminary results with 















    Unless mentioned otherwise, all non-aqueous reactions were carried out in vacuum-
flame-dried glasswares under a balloon-pressure of argon; reagents were commercially 
available and used as received; anhydrous solvents were purchased as the highest grade 
from Sigma-Aldrich, or passed through a solvent-purification system, or purified as 
following: THF was distilled from Na-benzophenone, CH2Cl2 was distilled from CaH2. 
Reactions were monitored by thin-layer chromatography on Merck silica gel 60-F254 
coated 0.25 mm plates. Flash column chromatography was performed using RediSep® 
pre-packed disposable silica gel columns (normal phase, 230-400 mesh) from Teledyne 
Isco. And prep-TLC was performed on Merck silica gel 60-F254 coated 0.50 or 1 mm 
plates. Yields were reported as isolated, spectroscopically pure compounds. And NMR 
spectra were obtained on Bruker DRX 300, or 400 MHz, or Bruker DMX 500 MHz 
spectrometers. CDCl3, dried by standing over K2CO3, was used and chemical shifts were 
referenced on residual solvent peaks (δ = 7.26 for 1H NMR and 77.00 for 13C NMR). 
Abbreviations for 1H NMR: s = singlet, d = doublet, t = triplet, q = quartlet, m = multiplet, 
or br = broad. IR spectra were obtained on a Perkin-Elmer Paragon 1000 FTIR 
spectrometer. And high resolution mass spectra were acquired from Columbia University 
Mass Spectral Core facility on a JEOL HX110 spectrometer. Optical rotations were 







    To a mixture of bromophenol 15457 (9.25 g, 42.6 mmol) and DMAP (98.6 mg, 0.81 
mmol) in 35 mL pyridine was added diethyl carbamyl chloride (5.40 mL, 44 mmol) at 
room temperature. The reaction mixture was stirred at reflux for 13 h under argon 
atmosphere. Then it was poured into ice water and extracted with ether for 3 times. The 
combined organic phases were washed with 1N HCl, brine and dried with anhydrous 
MgSO4 then filtrated. The residue was purified by flash chromatography (hexane / 
EtOAc: 92 / 8) to give 6.42 g desired product 155 in 48% yield (the step from 153 to 154 
was quantitative). 
 
1H NMR (400 MHz, CDCl3): δ 11.91 (s, 1H), 10.33 (s, 1H), 7.32 (d, J = 9.2 Hz, 1H), 
6.94 (d, J = 9.2 Hz, 1H), 3.50 (q, J = 7.2 Hz, 2H), 3.38 (q, J = 7.2 Hz, 2H), 1.30 (t, J = 
7.2 Hz, 3H), 1.21 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 196.86, 160.65, 
152.37, 141.11, 131.94, 120.39, 117.26, 116.84, 41.92, 41.49, 13.71, 12.74. IR (NaCl, 
cm-1): 2976, 2935, 1725, 1652, 1607, 1580, 1462, 1420, 1380, 1294, 1265, 1240, 1220, 




57 Li, C.; Johnson, R. R.; Porco, Jr. J. A. J. Am. Chem. Soc. 2003, 125, 5095 – 5106. 
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    To a solution of 155 (1.37 g, 4.34 mmol) and 2,6-lutidine (1.15 mL, 13.0 mmol) in 20 
mL of CH2Cl2 was added TBSOTf (1.19 mL, 5.16 mmol) slowly at 0 ℃. The reaction 
mixture was allowed to warm up to room temperature and stirred overnight. The reaction 
was quenched with saturated aqueous NH4Cl at 0 ℃ and extracted with ether for 3 times. 
The combined organic layers were washed with 1N HCl, saturated aqueous sodium 
bicarbonate, water and brine respectively, then dried over anhydrous MgSO4, 
concentrated and purified by flash chromatography (hexane / EtOAc: 92 / 8) to give 1.88 
g desired product 156 in 97% yield. 
 
1H NMR (300 MHz, CDCl3): δ 10.32 (s, 1H), 7.22 (d, J = 9.0 Hz, 1H), 6.81 (d, J = 9.0 
Hz, 1H), 3.47 (q, J = 7.2 Hz, 2H), 3.35 (q, J = 7.2 Hz, 2H), 1.27 (t, J = 7.2 Hz, 3H), 1.15 
(t, J = 7.2 Hz, 3H), 0.96 (s, 9H), 0.21 (s, 6H). 13C NMR (75 MHz, CDCl3): δ 189.6, 155.7, 
153.0, 143.4, 128.6, 126.2, 119.6, 118.0, 42.3, 41.9, 25.5, 18.1, 14.1, 13.1, -4.5. IR (NaCl, 
cm-1): 2932, 2859, 1727, 1702, 1591, 1562, 1462, 1420, 1393, 1243, 1221, 1153. HR-MS 




























58% for 3 steps
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    To a stirred solution of 156 (1.89g, 4.40 mmol) in 50 mL dichloromethane was added 
mCPBA (3.79g, 77% max.) at 0 ℃, and the solution was slowly warmed up to room 
temperature and stirred for 1 day. The reaction was quenched by NH4Cl (sat.) solution at 
0 ℃, and after seperation the aqueous phase was re-extracted by EtOAc three times, the 
combined EtOAc solution was added hexanes, and then washed with NaHCO3 (sat.) and 
brine sequentially and dried over MgSO4, the filtrate was evaporated and the crude 157 
was directly used in the next step. 
    157 was dissolved in 50 mL methanol, and K2CO3 (1.50 g) was added at 0 ℃, the 
reaction mixture was warmed up to room temperature and stirred for 0.5 hr. The reaction 
was quenched by NH4Cl (sat.) at 0 ℃, and the aqueous phase was extracted with Et2O 
three times. The organic phase was evaporated and then re-dissolved in Et2O, and 
hexanes were added, then washed with NH4Cl (sat.) and brine. After drying over MgSO4, 
the filtrate was evaporated and the crude product 158 was directly used in the next step. 
    158 was dissolved in 50 mL dichloromethane and cooled to 0 ℃, diisopropylamine 
(6.17 mL, 35.2 mmol) was added, followed by MOMCl (1.34 mL, 17.6 mmol). The 
reaction mixture was evaporated 1 h later and the residue was chromatographed 
(hexanes:EtOAc = 9:1 to 7:1) and gave the desired product 159 (1.17 g, 2.53 mmol, 58% 
yield for 3 steps). 
159: 
1H NMR (400 MHz, CDCl3): δ 6.87 (d, J = 8.8 Hz, 1H), 6.79 (d, J = 8.8 Hz, 1H), 5.16 (s, 
2H), 3.63 (s, 3H), 3.48 (q, J = 7.2 Hz, 2H), 3.38 (q, J = 7.2 Hz, 2H), 1.29 (t, J = 7.2 Hz, 
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3H), 1.20 (t, J = 7.2 Hz, 3H), 0.98 (s, 9H), 0.19 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 
153.30, 146.40, 146.33, 143.57, 119.40, 118.71, 113.26, 98.69, 58.22, 42.30, 41.94, 25.61, 
18.14, 14.17, 13.27, -4.51. IR (NaCl, cm-1): 2955, 2931, 2857, 1727, 1483, 1469, 1416, 




(Caution: the sealed tube must be thick and strong enough, and a blast shield is needed) 
In a flame-dried seal tube was charged bromide 159 (37 mg, 0.080 mmol) in 1 mL 
Et2O, and cooled to -78℃  and t-BuLi (1.7 M in pentane, 0.160 mmol) was added 
dropwise and stirring continued for 10 min. Then aldehyde 3617a,c (32.8 mg, 0.073 mmol) 
in 2 mL Et2O was added dropwise, and was stirred for 10 min. The reaction mixture was 
warmed to room temperature and then heated at 130 ℃  oil bath for 4 hrs before 
quenching by brine at room temperature. The two phases were separated and the aqueous 
phase was re-extracted by Et2O twice. The combined organic phase was dried over 
MgSO4, and after filtered and evaporated, the residue was chromatographed by prep-TLC 
(hexanes:EtOAc = 50:1) and gave desired product 160 (10:1 d.r. at C8, 31.1 mg, 60% 
yield). 
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In a large scale reaction, 11.27 g bromide 159 and 9.98 g aldehyde 36 (both divided 
into two identical batches for reaction and then combined during work-up) gave 8.14 g 

































(Caution: the sealed tube must be thick and strong enough, and a blast shield is needed) 
In a sealed tube was charged 160 (446 mg, 0.623 mmol) in 10 mL THF, and the vessel 
was placed in a 192 ℃ oil bath and heated for 11 hrs. The sealed tube was cooled to room 
temperature and added 10 mL MeOH and I2 (14.7 mg, 0.058 mmol). 3 hrs later, the 
reaction was quenched by 10% Na2S2O3 solution until color faded. The mixture was 
evaporated and then partitioned by Et2O and brine and separated. The aqueous phase was 
re-extracted by Et2O twice and the combined organic phase was dried over MgSO4, and 
the filtrate was evaporated and chromatographed, providing 162 (204.4 mg, 0.339 mmol, 




    161 (20.4 mg, 0.034 mmol) was dissolved in 1 mL dichloromethane and imidazole 
(31.8 mg, 0.467 mmol) and TBSCl (43.9 mg, 0.291 mmol) were added sequentially. The 
reaction mixture was stirred overnight before quenched by NH4Cl (sat.), Et2O and brine 
were added, and the separated aqueous phase was re-extracted with Et2O twice. The 
combined organic phase was dried over MgSO4 and filtered, and the filtrate was 
evaporated and prep-TLC (hexanes:EtOAc = 10:1) gave the desired product 160 (22.0 
mg, 0.031 mmol, 91% yield). This product can be used for the preceding epimerization 
reaction. 
160: 
1H NMR (400 MHz, CDCl3): δ 6.62 (d, J = 8.8 Hz, 1H), 6.55 (s, 1H), 6.51 (d, J = 8.8 Hz, 
1H), 6.25 (d, J = 9.6 Hz, 1H), 6.17 (d, J = 9.2 Hz, 1H), 5.16 (d, J = 6.0 Hz, 1H), 5.10 (d, 
J = 6.0 Hz, 1H), 3.83 (t, J = 8.4 Hz, 1H), 3.53 (s, 3H), 3.65 – 3.50 (m, 2H), 2.15 – 1.91 
(m, 4H), 1.86 – 1.78 (m, 1H), 1.75 – 1.67 (m, 1H), 1.61 – 1.51 (m, 1H), 1.00 (s, 9H), 
0.903 (s, 9H), 0.896 (s, 3H), 0.83 (s, 9H), 0.18 (s, 3H), 0.17 (s, 3H), 0.07 (s, 3H), 0.05 (s, 
3H), -0.05 (s, 3H), -0.07 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 146.96, 144.07, 141.48, 
139.09, 134.72, 126.66, 120.25, 119.53, 114.36, 111.86, 98.83, 76.84, 76.78, 59.11, 57.60, 
47.84, 46.34, 39.55, 30.69, 25.81, 25.75, 19.23, 18.15, 18.04, 12.82, -4.36, -4.45, -4.48, -
4.84. [α]D20: +41.44 (c = 0.93, CH2Cl2). IR (NaCl, cm-1): 2955, 2929, 2893, 2857, 1570, 
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1471, 1387, 1251, 1176, 1162, 1094, 1000. HR-MS (FAB+) calcd for C39H68O6Si3 (M+): 
716.4324, found 716.4312. 
8-epi-160: 
1H NMR (400 MHz, CDCl3): δ 6.60 (d, J = 8.4 Hz, 1H), 6.53 (s, 1H), 6.46 (d, J = 8.8 Hz, 
1H), 6.01 (d, J = 9.6 Hz, 1H), 5.92 (d, J = 9.6 Hz, 1H), 5.13 (d, J = 6.0 Hz, 1H), 5.10 (d, 
J = 6.0 Hz, 1H), 3.82 – 3.63 (m, 3H), 3.52 (s, 3H), 2.25 (dd, J = 13.2, 6.4 Hz, 1H), 2.21 – 
1.87 (m, 4H), 1.85 – 1.72 (m, 1H), 1.55 – 1.45 (m, 1H), 1.07 (s, 3H), 0.98 (s, 9H), 0.91 (s, 
9H), 0.80 (s, 9H), 0.16 (s, 3H), 0.15 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H), -0.08 (s, 3H), -
0.10 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 147.41, 144.03, 141.71, 137.02, 136.52, 
125.45, 120.35, 118.60, 114.96, 111.38, 98.91, 78.77, 78.02, 59.40, 57.71, 50.59, 47.05, 
38.42, 30.56, 25.93, 25.81, 25.75, 20.85, 18.26, 18.17, 18.05, 13.98, -4.43, -4.46, -4.53, -
4.88, -5.26, -5.34. [α]D19: -1.19 (c = 2.20, CH2Cl2). IR (NaCl, cm-1): 2953, 2928, 2887, 
2857, 1571, 1471, 1384, 1295, 1252, 1161, 1121, 1088. HR-MS (FAB+) calcd for 
C39H68O6Si3 (M+): 716.4324, found 716.4319. 
161: 
1H NMR (400 MHz, CDCl3): δ 6.63 (d, J = 8.8 Hz, 1H), 6.58 (s, 1H), 6.51 (d, J = 8.8 Hz, 
1H), 6.24 (d, J = 9.6 Hz, 1H), 6.19 (d, J = 9.2 Hz, 1H), 5.16 (d, J = 6.0 Hz, 1H), 5.09 (d, 
J = 6.0 Hz, 1H), 3.86 (t, J = 8.4 Hz, 1H), 3.75 – 3.66 (m, 1H), 3.64 – 3.57 (m, 1H), 3.53 
(s, 3H), 2.21 – 2.01 (m, 3H), 1.91 (dd, J = 12.4, 7.2 Hz, 1H), 1.78 – 1.53 (m, 4H), 1.00 (s, 
9H), 0.91 (s, 3H), 0.90 (s, 9H), 0.19 (s, 3H), 0.18 (s, 3H), 0.08 (s, 3H), 0.06 (s, 3H). 13C 
NMR (100 MHz, CDCl3): δ 146.49, 144.08, 141.81, 139.36, 134.61, 126.38, 120.35, 
119.44, 114.56, 111.81, 98.82, 77.12, 76.68, 59.28, 57.58, 48.28, 46.59, 39.62, 30.73, 
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25.80, 25.73, 19.61, 18.14, 18.02, 12.83, -4.34, -4.43, -4.81. [α]D21: +31.43 (c = 0.81, 
CH2Cl2). IR (NaCl, cm-1): 3417, 2954, 2929, 2886, 2857, 1471, 1361, 1295, 1250, 1159, 
11161046, 998. HR-MS (FAB+) calcd for C33H54O6Si2 (M+): 602.3459, found 602.3461. 
162: 
1H NMR (400 MHz, CDCl3): δ 6.60 (d, J = 8.8 Hz, 1H), 6.55 (s, 1H), 6.46 (d, J = 8.4 Hz, 
1H), 6.02 (d, J = 9.6 Hz, 1H), 5.93 (d, J = 9.2 Hz, 1H), 5.14 (d, J = 6.0 Hz, 1H), 5.07 (d, 
J = 6.0 Hz, 1H), 3.82 – 3.65 (m, 3H), 3.52 (s, 3H), 2.30 (dd, J = 13.6, 6.4 Hz, 1H), 2.27 – 
2.18 (m, 1H), 2.11 – 1.91 (m, 3H), 1.90 – 1.78 (m, 1H), 1.73 (s, br, 1H), 1.57 – 1.47 (m, 
1H), 1.06 (s, 3H), 0.98 (s, 9H), 0.91 (s, 9H), 0.17 (s, 3H), 0.16 (s, 3H), 0.05 (s, 3H), 0.03 
(s, 3H). 13C NMR (100 MHz, CDCl3): δ 147.16, 143,98, 141.95, 137.16, 136.33, 125.39, 
120.41, 118.55, 115.04, 111.22, 98.82, 79.32, 78.03, 59.40, 57.64, 50.70, 47.10, 37.54, 
30.55, 25.80, 25.71, 20.57, 18.13, 18.02, 13.98, -4.46, -4.90. [α]D20: +4.75 (c = 2.04, 
CH2Cl2). IR (NaCl, cm-1): 3413, 2955, 2929, 2892, 2857, 1472, 1386, 1296, 1252, 1159, 
1120. HR-MS (FAB+) calcd for C33H54O6Si2 (M+): 602.3459, found 602.3476. 
 
 
    To a stirred solution of 162 (338.4 mg, 0.56 mmol) in 2 mL dichloromethane was 
added pyridine (0.20 mL), 4-dimethylaminopyridine (10.5 mg), p-toluenesulfonyl 
chloride (300.2 mg, 1.57 mmol). The reaction mixture was stirred overnight before 
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quenched by NH4Cl (sat.), then Et2O and brine were added, and the separated aqueous 
phase was re-extracted with Et2O twice. The combined organic phase was dried over 
MgSO4 and filtered, and the filtrate was evaporated and flash column chromatography 
(hexanes:EtOAc = 1:0 to 9:1) gave the desired product 163 (403.8 mg, 0.533 mmol, 95% 
yield). 
1H NMR (400 MHz, CDCl3): δ 7.65 (d, J = 8.4 Hz, 1H), 7.27 (d, J = 8.4 Hz, 1H), 6.56 (d, 
J = 8.4 Hz, 1H), 6.53 (s, 1H), 6.32 (d, J = 8.8 Hz, 1H), 5.98 (d, J = 9.6 Hz, 1H), 5.90 (d, J 
= 9.6 Hz, 1H), 5.11 (d, J = 6.0 Hz, 1H), 5.06 (d, J = 6.0 Hz, 1H), 4.20 – 4.11 (m, 1H), 
4.11 – 4.03 (m, 1H), 3.72 (t, J = 8.0 Hz, 1H), 3.50 (s, 3H), 2.43 (s, 3H), 2.28 – 2.10 (m, 
3H), 2.05 – 1.94 (m, 1H), 1.91 – 1.82 (m, 1H), 1.68 – 1.55 (m, 1H), 1.52 – 1.41 (m, 1H), 
1.00 (s, 9H), 0.94 (s, 3H), 0.91 (s, 9H), 0.19 (s, 3H), 0.17 (s, 3H), 0.04 (s, 3H), 0.03 (s, 
3H). 13C NMR (100 MHz, CDCl3): δ 146.72, 144.44, 143.99, 142.05, 137.04, 135.19, 
132.93, 129.66, 127.79, 125.16, 120.56, 118.35, 115.50, 111.22, 98.75, 77.81, 77.74, 
66.96, 57.59, 50.23, 46.88, 34.11, 30.41, 25.74, 25.69, 21.52, 20.53, 18.10, 17.96, 13.78, 
-4.50, -4.95. [α]D19: +24.37 (c = 2.39, CH2Cl2). IR (NaCl, cm-1): 2954, 2929, 2887, 2857, 
1472, 1386, 1363, 1252, 1178, 1124. HR-MS (FAB+) calcd for C40H60O8Si2S (M+): 



















    To a vial with 2 mL THF solution of 163 (46.6 mg, 0.062 mmol) was added TBAF 
(1.0 M in THF, 0.065 mL), after stirring for 5 min, the reaction mixture was heated at 70 ℃ 
for 30 min. The vial was cooled to r.t. and all the volatiles were evaporated, and flash 
column chromatography (hexanes:EtOAc = 9:1) gave the desired product 164 (27.3 mg) 
in 94% yield. 
1H NMR (400 MHz, CDCl3): δ 6.86 (d, J = 10.0 Hz, 1H), 6.53 (s, 1H), 6.25 (d, J = 9.6 
Hz, 1H), 6.22 (d, J = 10.0 Hz, 1H), 6.05 (d, J = 9.6 Hz, 1H), 5.15 (d, J = 6.0 Hz, 1H), 
5.10 (d, J = 6.0 Hz, 1H), 3.85 (t, J = 8.4 Hz, 1H), 3.51 (s, 3H), 2.31 – 1.96 (m, 5H), 1.93 
– 1.86 (m, 1H), 1.80 – 1.65 (m, 2H), 1.60 – 1.50 (m, 1H), 0.95 (s, 3H), 0.91 (s, 9H), 0.06 
(s, 3H), 0.04 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 181.80, 150.47, 147.15, 144.21, 
142.36, 140.68, 129.07, 125.53, 115.52, 97.72, 85.19, 77.32, 77.13, 57.48, 47.45, 46.14, 
37.72, 30.35, 29.44, 25.78, 19.18, 18.02, 14.96, -4.41, -4.90. [α]D20: +109 (c = 2.20, 
CH2Cl2). IR (NaCl, cm-1): 2954, 2928, 2896, 2855, 1659, 1633, 1583, 1149, 1119, 1018. 
HR-MS (FAB+) calcd for C27H39O5Si (M + 1): 471.2567, found 471.2576. 
 
 
To a stirred solution of 164 (51 mg, 0.11 mmol) in 2 mL THF was added L-Selectride 
(1.0 M, 0.12 mL) at -78 ℃, 20 min later, 5,5-dibromo-Meldrum’s acid (39.5 mg, 0.13 
mmol) was added in one portion. 0.5 hr later, the reaction was quenched by adding 
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NH4Cl (sat.), then EtOAc and brine were added, and the separated aqueous phase was re-
extracted with EtOAc twice. The combined organic phase was dried over MgSO4 and 
filtered, and the filtrate was evaporated and flash column chromatography 
(hexanes:EtOAc = 9:1) gave the desired product 165 (38 mg, 0.069 mmol, 62% yield). It 
is recommended that the product should be used in the next step as soon as possible. 
1H NMR (400 MHz, CDCl3) key peaks: δ 6.46 (s, 1H, a-Br-165), 6.41 (s, 1H, e-Br-165), 
4.80 (dd, J = 14.0, 5.2 Hz, 1H, e-Br-165), 4.68 (dd, J = 4.8, 2.0 Hz, 1H, a-Br-165). HR-
MS (FAB+) calcd for C27H40O579BrSi (M + 1): 551.1828, found 551.1854. 
 
 
To a stirred solution of 165 (111.9 mg, 0.203 mmol) in 5 mL THF was added 
tetrabutylammonium azide (103.0 mg, 0.363 mmol) in one portion, and 50 min later, the 
solvent was evaporated and the crude mixture of 166 was covered by argon and directly 
used in the next step. 
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The crude mixture 166 was re-dissolved in dichloromethane and NaBH3(CN) (36 mg) 
was added, followed by adding HOAc (0.40 mL) dropwise. 5 min later, 138 mg 
NaBH3(CN) was added in 3 portions, and the reaction mixture was stirred for 10 min 
before quenched by adding NaHCO3 (sat.) slowly. The two phases were separated and 
the aqueous phase was re-extracted by dichloromethane, and the combined 
dichloromethane solution was evaporated and used in the next step quickly. The product 
167 is a little air-sensitive, and quick operation is recommended. 
To a stirred solution of 167 in 10 mL methanol was added methanol solution (10 mL) 
of CeCl3·7H2O (0.18 g), and stirring continued for 2 min at 0 ℃. NaBH4 (0.20 g + 0.24 g 
+ 0.21 g) was added in three portions with an interval of 15 min, and the total reaction 
last for 1 hr. Methanol was evaporated and Et2O, brine and NH3·H2O (28%) were added, 
and the organic phase was separated and the aqueous phase was re-extracted with Et2O 
twice. The combined organic phase was dried over Na2SO4, and prep-TLC 
(dichloromethane:methanol = 5:1, with a few drops of NH3·H2O) gave the desired 
product 168 (41.4 mg, 0.085 mmol, 42% yield from 165). 
168: 
1H NMR (400 MHz, CDCl3): δ 6.13 (s, 1H), 6.00 (d, J = 9.2 Hz, 1H), 5.92 (d, J = 9.6 Hz, 
1H), 4.98 (d, J = 6.4 Hz, 1H), 4.89 (d, J = 6.4 Hz, 1H), 4.06 (d, J = 8.0 Hz, 1H), 3.79 (t, J 
= 8.0 Hz, 1H), 3.52 (s, 3H), 3.01 (m, 1H), 2.21 – 1.45 (m, 11H), 0.90 (s, 12H, C18 
methyl and tert-butyl), 0.05 (s, 3H), 0.03 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 145.18, 
144.48, 137.99, 126.14, 125.58, 114.87, 96.60, 82.10, 78.59, 77.54, 73.73, 56.83, 52.57, 
47.03, 46.42, 41.42, 39.36, 33.26, 30.55, 25.74, 19.25, 17.95, 14.30, -4.47, -4.96. [α]D19: 
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+2.18 (c = 1.51, CH2Cl2). IR (NaCl, cm-1): 3351, 3287, 2954, 2931, 2886, 2858, 1639, 
1470, 1386, 1360, 1303, 1254, 1155, 1119, 1009. HR-MS (FAB+) calcd for C27H44O5NSi 
(M + 1): 490.2989, found 490.3006. 
 
 
To a stirred solution of 168 (41.4 mg, 0.085 mmol) in 3 mL dioxane was added 0.50 
mL 10% aq. Na2CO3, and then a solution of 125.0 mg Fmoc-OSu in 2 mL dioxane was 
added. 2 hrs later, the reaction mixture was evaporated and the residue was taken up by 
Et2O, brine and NH4Cl (sat.), and separated. The aqueous phase was re-extracted by Et2O 
twice, and the combined organic phase was dried over Na2SO4, and then evaporated, the 
crude mixture of 170 was directly used in the next step. 
The mixture of 170 was dissolved in 20 mL dichloromethane, and 4-
dimethylaminopyridine (48.0 mg) was added, followed by pyridine (0.40 mL). Acetic 
anhydride (0.25 mL) was then added dropwise. 10 min later, evaporated all volatiles and 
the residue was purified by flash column chromatography (hexanes:EtOAc = 4:1) and 
gave the desired product 202 (44.5 mg, 0.059 mmol) in 70% yield for 2 steps. 
202: 
1H NMR (500 MHz, CDCl3): δ 7.76 (d, J = 7.5 Hz, 2H), 7.58 (d, J = 7.0 Hz, 2H), 7.40 (t, 
J = 7.5 Hz, 2H), 7.32 (d, J = 7.5 Hz, 2H), 6.16 (s, 1H), 6.05 (d, J = 9.0 Hz, 1H), 5.94 (d, J 
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= 9.5 Hz, 1H), 5.68 (d, J = 8.5 Hz, 1H), 5.17 (d, J = 7.5 Hz, 1H), 4.86 (d, J = 6.0 Hz, 1H), 
4.77 (d, J = 6.0 Hz, 1H), 4.40 – 4.38 (m, 2H), 4.22 (t, J = 7.5 Hz, 1H), 4.06 – 4.00 (m, 
1H), 3.80 (t, J = 8.0 Hz, 1H), 3.43 (s, 3H), 2.28 – 1.48 (m, 11H), 0.91 (s, 3H), 0.90 (s, 
9H), 0.05 (s, 3H), 0.03 (s, 3H). 13C NMR (125 MHz, CDCl3): δ 171.55, 155.79, 146.30, 
143,78, 141.24, 140.03, 138.99, 130.03, 127.66, 127.03, 125.45, 125.09, 119.94, 114.48, 
97.52, 82.44, 77.86, 77.53, 71.67, 66.94, 56.98, 51.17, 47.15, 47.11, 46.37, 39.37, 38.47, 
32.97, 30.53, 25.79, 21.06, 19.23, 18.01, 14.34, -4.42, -4.91. [α]D18: +65.27 (c = 2.95, 
CH2Cl2). IR (NaCl, cm-1): 3314, 2955, 2930, 2886, 2857, 1736, 1694, 1641, 1549, 1450, 
1375, 1297, 1260, 1233, 1159, 1119, 1016. HR-MS (FAB+) calcd for C44H55O8NSi (M+): 
753.3697, found 753.3690. 
 
 
To a solution of 202 (43.8 mg, 0.058 mmol) in 2 mL THF was added 0.5 mL water, 
and the reaction mixture was cooled to 0℃. Then 0.10 mL solution of Br2 in THF (made 
by adding 0.033 mL Br2 into 1.0 mL THF) was added dropwise, and the whole reaction 
mixture was stirred for 2 min before quenching by 10% aqueous solution of Na2S2O3. 
Et2O and brine were added, and the two layers were separated. The organic layer was re-
extracted by Et2O twice. The combined organic phase was dried over MgSO4, and after 
filtration, the solvent was evaporated. The crude mixture 203 (about 49.1 mg) was 
directely used in the next step. 
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The crude mixture 203 was evenly divided into three batches. In each batch, 16.4 mg 
crude 203 was dissolved in 0.8 mL C6D6 in a J-Young NMR tube, and then a C6D6 
solution of AIBN (2 mg in 0.20 mL C6D6) was added. The whole mixture was degassed 
twice (freeze-pump-thaw) and refilled with Ar. Then 0.030 mL n-Bu3SnH was added, 
and the reaction mixture was further degassed four times before immersed in a 70℃ oil 
bath. The reaction was carefully monitored by 1H NMR, and 4 hrs later, the reaction 
mixture was cooled and combined. After evaporating all the volatiles, prep-TLC 




Intermediate 204 was dissolved in 1 mL dichloromethane/MeOH (1:1) solution, and 
the reaction mixture was cooled to 0 ℃. CeCl3•7H2O (7.6 mg) was added, and NaBH4 
(5.2 mg) was added to this stirred mixture 2 min later. The reaction was quenched by 
NH4Cl (sat.) after 5 min, and brine and dichloromethane was added. The separated 
aqueous layer was re-extracted with dichloromethane twice, and the combined organic 
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phase was dried over MgSO4. After filtration, the solvent was evaporated and prep-TLC 
gave the crude product 204’ (4.4 mg) which was directly used in the next step. 
 
 
Intermediate 204’ was dissolved in 1 mL dichloromethane, 5.5 mg DMAP and 0.040 
mL pyridine were added. Then 0.030 mL Ac2O was added dropwise. MeOH was added 
10 min later and after 2 min, all volatiles were evaporated and prep-TLC (hexanes:EtOAc 
= 3:2) gave the desired product 205 (2.9 mg, 7% from 202). 
205: 
1H NMR (400 MHz, CDCl3): δ 7.76 (d, J = 7.2 Hz, 2H), 7.56 (t, J = 6.8 Hz, 2H), 7.40 (t, 
J = 7.2 Hz, 2H), 7.31 (d, J = 7.6 Hz, 2H), 5.81 (s, 1H), 5.61 (d, J = 9.2 Hz, 1H), 5.44 (m, 
1H), 5.17 (d, J = 8.4 Hz, 1H), 4.92 (t, J = 8.8 Hz, 1H), 4.34 (m, 2H), 4.20 (t, J = 7.2 Hz, 
1H), 3.93 (m, 1H), 3.77 (t, J = 8.4 Hz, 1H), 2.15 (s, 3H), 2.02 (s, 3H), 2.36 – ca. 1.20 (m, 
13H), 0.89 (s, 9H), 0.74 (s, 3H), 0.04 (s, 6H). IR (NaCl, cm-1): 2954, 2928, 2857, 1741, 
1540, 1450, 1376, 1278, 1246, 1143, 1106, 1021. HR-MS (FAB+) calcd for C44H56O8NSi 
(M + 1): 754.3775, found 754.3773. 
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